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Abstract 
Lab-on-a-chip (LOC) technology has advanced over the past several decades. As 
miniaturized multiphase multistep reactors, LOCs are suitable for the implementation of 
complex liquid phase reactions in the field of biomedical detection. This doctoral thesis 
focused on the development of new LOC devices and relevant functionalities for various 
application cases, including microbe detection, water-safety testing, while also presenting 
preliminary studies on the measurement of signal molecules in blood. 
The application-oriented R&D (research and development) strategy was employed in the 
studies on a series of biomedical LOC devices. Technological challenges, e.g. 
optimization of on-chip quantification NASBA (nucleic acid sequence-based 
amplification) protocols, system design etc. were resolved in individual cases. Based on 
a low-cost R&D strategy, most LOCs in this doctoral work were developed for bench-top 
equipment as disposable components. It is worth noting that a methodological concept is 
also developed and summarized in this thesis, i.e., the selection of decision support 
mechanisms (DSMs) for biomedical LOC devices. 
The DSM is the supporting mechanism generating measurable signals in the LOC, and 
translating them into a meaningful conclusion, which can help users to make decisions in 
the real application field. 
Namely, DSMs can enable LOC-based testing and are thus a distinguished feature of 
application-oriented LOC devices. The author categorized the research achievements 
presented in this thesis into three distinctive classes, as follows: 
1) Conventional DSMs commonly employed in current biomedical experimental 
approaches. 
Articles I, II and III focus on this category of DSMs. The series of LOCs in these reports 
were modelled on standard microtiter plates, and thus these chips are completely 
compatible with the microplate readers commonly utilized in biological laboratories. 
Article I reported the design, fabrication and validation of a disposable 43-chamber LOC 
device for quantitative detection of waterborne pathogens. Its principle was similar to 
conventional ELISA(enzyme-linked immunosorbent assay) tests for microbes, entitled 
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immuno-NASBA assay. A synthetic peptide and two common waterborne pathogens 
(Escherichia coli and rotavirus) in artificial samples were used to validate the LOC 
functions, which indicated that the LOC device has the potential to quantify traces of 
waterborne pathogens with high specificity. 
Article II described the development of a LOC platform for environmental investigations 
into aquatic microorganisms, on the basis of quantitative NASBA (Q-NASBA). The LOC 
system was composed of a membrane-based sampling module, a sample preparation 
cassette, and a 24-channel Q-NASBA chip. The DSM of the LOC was derived from the 
polyurethane-foam-unit (PFU) method, which has been widely used to evaluate 
environmental pollution in fresh water. The multifunctional system could simplify and 
standardize the complicated processes of microbial detection. 
Article III addressed the implementation of a 384-chamber microfluidic simulator with 
the incorporated functions of pathogen identification and antimicrobial susceptibility 
testing (AST) for personalizing the antibiotic treatment of urinary tract infections (UTIs). 
Its DSM adopted the diagnosis principle of conventional ATP bioluminescence assay 
(ATP-BLA) for living microbial cells. 
2) Unconventional DSMs for contrived LOC systems. 
The second class of biomedical LOCs employs tailored DSMs, which are still derived 
from known working principles. However, the concrete mechanisms and diagnostic 
criteria are arbitrary in contrived functional LOCs.  
Article IV investigated a bioluminescent-cell-based continuous-flow device, termed a 
‘living-cell chip’, with a self-defining DSM to implement real-time broad-spectrum 
online monitoring of water quality. The prototype integrated a T-junction droplet 
generator, counter-flow micro-mixers, and time-delay channels. The LOC device can mix 
the water sample and Vibrio fischeri cell sensors into a droplet flow, and incubate the 
droplets in the time-delay channels before optical detection. Its DSM relies upon the 
relationship between the toxicant concentration in the water sample and the relative 
luminescence units of the bioluminescent cells in the running droplets, which is obviously 
different from the conventional intermittent method of ISO11384. The proposed LOC 
system shows great promise for an early warning system against potential toxicant 
chemicals in drinking water. 
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3) Developing prognostic/diagnosis DSMs for biomedical-database-dependent LOC 
systems with the aid of computational modelling. 
The third category relies on computational modelling within a large-scale 
medical/healthcare database, which is currently emerging and is not yet completely 
developed. 
Article V reported a pilot study on the design and fabrication of the LOC device for signal 
molecule profiling in blood. Articles VI proposed the potential roadmap and preliminary 
experimental approach for the construction of a human signal-molecule-profiling 
database (HSMPD) by the use of the former LOC device, leading to prognostic/diagnosis 
DSMs in the future. 
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ACTH: adrenocorticotropic hormone; 
AST: antimicrobial susceptibility testing; 
ATP: adenosine triphosphate; 
ATP-BLA: ATP bioluminescence assay; 
BOD: biochemical oxygen demand; 
CFU: Colony-forming unit; 
CLIA: chemiluminescent immunoassay; 
CMV: culture medium veins; 
CPC: cetylpyridinium chloride; 
Ct: the threshold time; 
Dabcyl: 4-[4-(Dimethylamino)phenylazo]benzoic acid N-succinimidyl ester; 
DEP: dielectrophoretic; 
DEPC: diethyl pyrocarbonate; 
DNA: deoxyribonucleic acid; 
DSM: decision support mechanism; 
Notes: The DSM is the supporting mechanism generating measurable signals in 
the LOC, and translating them into a meaningful conclusion, which can help users 
to make decisions in the real application field. 
EGF: epidermal growth factor; 
ELISA: enzyme-linked immunosorbent assay; 
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1 Introduction 
Lab on a chip (LOC) refers to a precision instrument-related microchip of only a few 
square millimetre or centimetre sizes. A LOC is able to perform one or more functional 
laboratorial tests. It can handle very small volumes of biological fluids with complex 
biochemical reactions, and can finally output useful information or perform special 
functions. 
The ability to perform laboratory operations on a small scale using miniaturized LOC 
devices is very appealing to end users.1 Small volumes will reduce the time taken to 
synthesize and analyse a product; the unique behaviour of liquids at the micro scale allows 
greater control of molecular concentrations and interactions, and reagent costs and the 
amount of chemical waste can be much reduced.1 In particular, LOC technology in the 
relevant fields of life science has broad application prospects. Biomedical LOC devices 
involve interdisciplinary knowledge of microsystems, microfluidics, mechanical 
engineering, surface physics, biochemistry, medical science etc. Although LOC 
technology has been studied for several decades, the majority of relevant research 
achievements currently stay in the laboratory stage, instead of entering the application 
stage. This doctoral thesis focuses on the challenges with regard to the application-
oriented LOC technology in the biomedical field. 
1.1 Background of application-oriented LOC systems 
Probably owning to the interest tendency of LOC researchers, a large number of LOC-
related projects have focused onto the academic value, instead of the applications and 
social impacts of the research achievements. However, the majority of relevant research 
achievements are currently on hold in the laboratory stage, instead of entering the 
commercial stage, implying that the research and development (R&D) strategy of LOC 
technology requires optimization. From the initial stages of R&D, the ultimate goals are 
to solve some of the existing problems in practice and to ensure that the innovative results 
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can be pragmatic. In fact, LOC technology is an innate applied science with great 
potential in the fields of biology and medicine, and has broad commercial prospects. The 
superiority of LOC systems is attributed to not only small sizes, but also other features 
derived from their spatial traits. When the volume of a biochemical reaction system is 
dramatically compressed, LOC exhibits some advantages which are the imperfection of 
conventional bench-top devices (Figure 1). The advantages of biomedical LOCs are 
summarized as follows: 
 LOCs are particularly suitable for multiphase-involved multifield-coupling 
multistep biochemical assays. Besides, it is easy to implement large-scale parallel 
detection in one on-chip test, i.e., high-throughput testing; 
 LOCs are often small and portable, which can reduce material costs in the mass 
production afterwards; 
 Generally, LOCs are highly integrated; consequently, automation and 
standardization of LOC devices are easily realized; 
 Compared with conventional laboratory tests, the consumption of energy, reagents 
and tested samples in a LOC assay is rather low, but the useful information 
obtained from the tests could be the same; 
 Due to short diffusion distances, large specific surface areas, small heat capacity 
and other physical factors in the microscale, biochemical reactions probably 
achieve higher efficiency in LOCs; 
Currently, LOC technology is still developing. The possible application fields of LOCs 
are shown in Figure 2. For example, this study involved in two relevant application fields. 
The first field is medical detection and diagnosis, referring to varied biological samples 
and chemical solutions employed in multistep biological reactions, and the second field 
is water quality monitoring, particularly the detection of waterborne pathogens, which 
involves multistep biological testing of aquatic samples. 
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Figure 1. Technical superiority of biomedical LOCs. 
 
Figure 2. The concept of application-oriented biomedical LOC devices. 
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The application-oriented R&D strategy aims at a practical problem as the objective. The 
entire development cycle includes analysis, design, fabrication, validation and product 
optimization, focusing on the unique goal of resolving the targeted objective. Therefore, 
this R&D strategy has a fundamental guarantee that the research output will serve for 
practical demands. Moreover, actual conditions for the targeted objective will naturally 
exclude improper tracks within the technology roadmap for the system design, 
accordingly helping researchers reduce unnecessary efforts of R&D. The application-
oriented R & D strategy is selected in this study, shown in Figure 2, lower part. Typical 
fields for application-oriented LOCs are enumerated as follows: 
 Medical diagnosis and treatment 
Medical detection is relevant to the pre-treatment of heterogeneous biological 
mixtures, e.g. blood, urine, faeces etc. Biomedical testing often involves 
multiphase, multistep reactions, and makes extensive use of electric, magnetic 
fields and temperature control etc. Besides, more and more medical examinations 
require parallel detecting of multiple items in one sample simultaneously for the 
convenience of users. Obviously, LOC technology will perfectly match those 
requirements. Some commercial cases are demonstrated in Figure 3. 
In addition, if LOC tools dramatically increase the efficiency of medical 
detections, medical treatment programmes would be improved as well. Advanced 
tools in clinical medicine always play a key role in patient survival. For example, 
a patient in an emergency room is suspected to have some heart diseases. If a rapid 
diagnostic tool can return pivotal results on the spot, doctors are likely to give a 
reasoned treatment on the patient, rather than an empirical one. 
 
Figure 3. Examples of commercial LOC devices.2-5 (a) Samsung™ LABGEO IB10 
is a portable automatic immunoassay analyzer with centrifugal LOCs for blood testing;2 
(b) BaDx™ Portable Anthrax Detector;3 (c) LOC devices made from glass by Micronit™ 
Microfluidics BV;4 (d) MOPS (Missouri Osteochondral Allograft Preservation System): 
an example of tissue-on-a-chip.5 
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 Biological and pharmaceutical research 
Similarly, scientific research in biology research and drug development processes 
also involve the experiments concerning the sample treatment and identification 
of animal cells, tissues etc. High-throughput biomedical tests are always essential, 
see Figure 4. LOC technology shows great capabilities in this trajectory. 
 
Figure 4. Commercial high-throughput biochips.6-10 (a) Arrayit™ DNA 
microarrays-Pathways™ Focused Human Genome Microarrays enable targeted gene 
expression analysis of every major cellular pathway in the human body, which contains a 
complete set of 25,509 fully annotated human genes;10 (b) PathGEN® PathChip can detect 
the presence of >70,000 viruses and bacteria from human samples within 2 days.6,7 The 
PathChip runs on the Affymetrix GeneChip® System;8 (c) An Affymetrix GeneChip® 
instrument at the University of British Columbia (Canada).9 
 Water safety and environmental studies 
Water is the most important sustainable resource for urban populations. The 
enormous demand for water safety has led to the development of early warning 
technology for aquatic environment or municipal water consumption. Currently, 
the conventional monitoring technology for aquatic environments and distribution 
network of municipal water still rely upon the routine monitoring of some 
conventional parameters of water quality, such as pH, conductivity, free chlorine 
etc.11,12 In fact, current detection methods can provide blameless protection with 
respect to water safety, but LOC technology here could potentially improve the 
degree of security.11 Water quality monitoring, especially for the detection of 
waterborne pathogens, involves multiphase, multistep biochemical reactions, 
which is the suitable field for LOC technology13-15. 
 Food safety and agricultural research 
Food safety is also associated with public health. Since quality detections of food 
involve multiphase multistep biochemical reactions, LOC technology is also 
X. Zhao: Application-oriented microfluidic LOC devices for the detection of microorganisms, toxic chemicals and serological biomarkers 
6 
 
applicable in this field. The detection principle of these LOCs is similar to that for 
biology research. 
 Furthermore, other life sciences-related fields probably also refer to the applied 
research of LOC technology, as long as those fields involve multiphase multistep 
biochemical reactions, for instance, toxicology research, bioinformatics etc.16-18  
Among the relevant papers in this thesis, Articles I and II described the research work on 
the detection of pathogens in water.15,19,20 Article III focuses on microbial detection in the 
urine for UTI patients.15 Article IV reports on the studies on the continuous monitoring 
of toxic chemicals in water.21 Articles V and VI aim at the profiling test of signal 
molecules in human blood.18,22 Although these biomedical LOC devices are different and 
specific in the different application projects, commonness inside could be found. In 
general, the complete hardware of a concept LOC system is illustrated in Figure 5. 
At present, one of major challenges in LOC research is how to make it useful in varied 
applications. From an engineering point of view, most technical challenges of LOCs are 
surmountable. Generally, a core LOC component should have at least two functions, 
which are to take the role of a multiphase reactor for multistep biochemical reactions and 
to generate detection signals. Namely, most biomedical LOCs should be some kind of 
convertors that can extract useful information from the samples. To obtain useful 
information, a series of supporting modules are essential, because core LOC components 
often require supporting instrumentation to implement specific functions. Typical 
supporting modules in a LOC system are summarized as below: 
 The sampling module is responsible for sample collection and treatment, such as 
lysis, concentration and extraction. The refined outputs from the sampling module 
should be transferred into the LOC by specific interfaces, so the sampling module 
connects the macroscopic world and microscale channels in the LOC. Since high 
quality samples are important for quantitative analysis, sampling modules are 
often integrated partially or completely into LOCs, especially disposable LOCs, 
to reduce contamination and operating error. Furthermore, the complexity of 
biomedical samples and their viscousness often lead to the difficulty of thoroughly 
rinsing used vessels. Consequently, sampling modules and all sample-contact 
components have to be disposable. 
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Figure 5. Typical hardware design of a complete LOC system. 
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devices require the centrifugal field as the driving force.23 PCR-based LOCs also 
require corresponding temperature fields, because PCR reactions for gene 
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detection usually require at least three different temperatures. 24,25 Magnetic micro 
beads are employed in many biomedical LOCs.26,27 Inevitably, magnetic fields 
will be required in those LOC systems.26,27 In fact, a multi-physics environment 
is the essential condition for a biomedical LOC. 
 The function of measurement module is to read and amplify the signals on the 
LOCs, including denoising and other information processing. The core 
transducers are either integrated into the LOC core or arranged in the external 
reusable measurement module. 
 The input/output (I/O) module is responsible for transmitting the information 
obtained by the measurement module to end users. The form of the I/O module 
maybe rely on the computers, but it is possible to build it on a new platform, e.g. 
a smart phone. Nowadays, more and more information is delivered to users 
through the Internet and smart phones. Mobile phones can help biomedical LOC 
devices to provide a friendly user interface. 
 The automatic control module is the control centre of a LOC system. A complete 
LOC device should eventually develop into an easy-to-use automated system. 
Otherwise, LOCs will be nearly pointless to common users. Perhaps it is one of 
the reasons that many LOC prototypes have to be shelved in the laboratory. Owing 
to the rapid development of robotics, no significant challenges exist in the R&D 
of automatic control modules at present. 
Obviously, a complete LOC system is always a complex instrument. Under present 
technical conditions, it is almost impossible to make the overall cost of such a complex 
system be cheap. There are two R&D strategies for application-oriented LOC systems 
(Figure 5, Bottom part): 
 To develop a fully integrated system. 
All modules are miniaturized and highly integrated together to form a compact 
portable tool, such as micro total analysis systems (μTAS), point-of-care (POC) 
devices, etc. The integrated LOC system is also employed among some implanted 
medical devices. The application environment for the fully integrated system has 
strict limitations. For instance, implanted drug delivery devices will be used inside 
the human body for a long period to intelligently release specific drugs. Therefore, 
these implanted devices definitely should be much smaller than bench-top devices, 
and ought not to be heavy. Only a fully integrated LOC system can meet the 
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requirements in this case. Portable tools for rapid diagnosis on the spot are in 
demand in the emergency room, or a battlefield, or a disaster scene etc. 
However, it is difficult to reduce the fabrication cost of a complex functional POC 
instrument, let alone a medical LOC appliance. Once a medical instrument was in 
contact with an individual clinical sample, it is not allowed to reuse it. The cost of 
fully integrated LOC systems became a major obstacle in the road leading to 
commercialization. Integrated LOC systems might not be amenable to the most 
common biomedical cases. Only in some special situations, e.g., emergency 
cardiac treatment, fully integrated LOC devices could meet real demands. 
 To develop a divided LOC system 
Another strategy is to select the framework of divided LOC systems, in which an 
entire system is split into two parts, i.e. an integrated reusable manipulator or ‘chip 
reader’, and disposable low-cost microfluidic chips. The former part could be a 
laboratory bench-top device. The manipulator should be reusable, and the cost of 
single measurement could be cost-efficient; it could be a large bench-top instrument, 
sacrificing mobility and cost-efficiency. On the other hand, disposable microfluidic 
chips are required to be low-cost, but sacrificing a part of LOC functions. With regard 
to a variety of multistep accurate fluidic operations, the simplified LOCs need 
function compensation and support from the reusable instrument. Thus, the strategy 
can reduce the cost of a single measurement using a LOC system. 
Of course, compared with a fully integrated LOC device, the divided LOC system 
sacrifices efficiency and mobility. The microfluidic chips in such a divided LOC 
system turns into a low-cost component in the bench-top instrument to enhance its 
efficiency and convenience. Fortunately, divided LOC systems are able to fulfil the 
needs of users in common scenarios of biomedical fields, In particular, disposable 
LOCs could gain more acceptance because they can avoid the cleaning after testing 
medical or biological samples. In fact, sampling modules have been designed as 
disposable parts nowadays. Furthermore, the sampling modules are often integrated 
into the disposable LOCs directly. According to the strategy, disposable chips require 
cheap materials and cheap fabrication methods, such as injection moulding on 
polymers etc.28-30 The hardware cost of a divided LOC system can be reduced within 
an acceptable range, which is the key to the commercialization of LOCs.31,32  
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On the other hand, a functional LOC system definitely does not only rely on hardware 
support. Direct signals from the chip are only some kind of physical quantity rather than 
meaningful conclusions. Without a translation mechanism, those signals are of no use in 
practical scenarios. The key translation mechanism for a LOC system is a ‘decision 
support mechanism’ (DSM), which can generate measurable signals in the LOC, and 
translate these signals into a meaningful conclusion in the real application field. A DSM 
is an information bridge, connecting the microscale LOC and the macroscopic world of 
applications. If a LOC system lacks of its DSM, the LOC has to be confined in the 
theoretical stage since its output is pointless. The DSM is essential to all application-
oriented biomedical LOC systems. The roles of the modules in a LOC system are similar 
to those of the hardware in a PC, whereas the DSM is similar to the software system in a 
PC (Figure 6). The author of this PhD thesis describes the DSM concept as follows: 
A) Reaction principles of LOC detection 
The detection principle and biochemical methods might be modified in the 
microscale world of LOCs. The form of the output signals can also vary 
considerably from the original, e.g. optical, electromagnetic, electrochemical etc. 
However, the reaction has to serve the purpose of the LOC, and the reaction 
principle is also determined by the purpose. For example, in the LOC system in 
Article III, living microbe pathogens in the urine samples of patients with UTIs 
were selected as the detection target; ATP-bioluminescence assay was employed 
as the basic principle of measurement, because the method is suitable for 
measuring living cells, and living microbes contain higher ATP concentrations. 
The feature is different from non-living particles. The initial step of developing 
an application-oriented biomedical LOC is to determine the detection purpose, 
and then select an appropriate reaction principle before any design of hardware 
components. 
B) Criteria and scenarios for applications 
In the application cases, end users are often unconcerned about the specific 
reactions inside the microfluidic channels. Their concerns are the meaningful 
conclusions drawn by the LOC-based tests. DSM is critical here since it is 
responsible for interpreting the information of the LOC system. 
DSM will define the boundary conditions in a scenario for a specific purpose. For 
example, when a researcher starts to design a LOC to measure the concentration 
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of oestrogen in human blood, the physiological and pathological concentration 
ranges of oestrogen must be considered in the DSM, as well as other related 
factors e.g. the gender, age, etc. Otherwise, misleading results could be inferred, 
even if the on-chip tests were well performed. The LOC system requires 
developing a set of criteria to complete the interpretation regulations for the 
signals on LOCs. Despite the importance of DSMs, the existence of DSMs are 
often ignored in the publications concerning LOC systems. If the measuring 
window of a LOC device is far from the required range in its DSM, theoretically, 
the LOC system almost has no value in the target application. 
 
 
Figure 6. The roles and taxonomy of DSMs for a LOC system. 
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of DSMs for LOC systems (Figure 6, lower part) as follows: 
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1. Conventional DSMs in common with current biomedical experimental 
approaches. 
The overwhelming majority of biomedical LOC devices rely on existing diagnostic 
mechanisms in laboratories, because this strategy might reduce the difficulties in 
validating new LOC tools and avoid unnecessary interrogation of their working principles 
and diagnostic criteria. Thanks to the biological research of the last 70 years, biomedical 
experimental approaches have advanced significantly. In general, it is easy for LOC 
researchers to ascertain existing and confirmed biological methods for the detection of 
candidate targets, as well as the criteria and scenarios for specific applications. 
Developing a novel DSM without any specific purpose is risky. In this R&D model, LOC 
researchers only need to focus on how to miniaturize mature laboratory tests onto 
microfluidic chips. Of course, many technical challenges still exist. The most popular 
detection methods in LOCs are shown in Figure 6 (lower part). 
However, the design for these LOC systems have to be limited by conventional DSMs. 
After all, there is a huge difference between the microstructure environment and the 
conditions in a laboratory. For instance, mixing of samples and reagents in a tube is easy 
in a conventional laboratory, but become challenges to LOCs. Considering the cost of 
LOCs and existing capacity of microfabrication, sometimes, conventional detection 
methods have to be modified slightly. When the change is too large, DSMs will be 
regarded as unconventional ones. 
2. Unconventional tailored DSMs for contrived LOC systems on the basis of known 
principles. 
The second class of biomedical LOCs employs some kind of tailored DSM, which is 
derived from the basic working principles of existing laboratory experiments, but 
concrete mechanisms and diagnostic criteria are arbitrary in terms of contrived functional 
LOCs. Compared with Class 1, the freedom in the system design has been extended for 
improved system performance. Actually, there are some advantages in the micro-reactors 
of LOCs. At first, the diffusion distances in LOCs are short, which is conducive to 
molecular collision in the on-chip reaction. Second, when the movement of particles is 
restricted by microstructures, those particles are easy to capture and separate. Third, the 
consumption of LOCs is rather small, leading to low maintenance costs. Therefore, it is 
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conducive for LOCs to sustain a long-term working style. According to these superior 
characteristics, conventional DSMs can be greatly modified for some LOCs to 
theoretically create outstanding detection systems. 
Unfortunately, unconventional DSMs have to answer more questions or be subject to 
censure. In reality, verification of new methods and new tools is always required in large-
scale and long-term experiments. If standard detection methods already exist, the 
challenges of these new methods increase, possibly only due to psychological factors. 
The large-scale validation experiments always need more financial support, which is an 
uncontrollable risk for most researchers. Therefore, most LOC developers prefer 
conventional DSMs, even though tailored DSMs probably lead to better performance. 
3. Developing prognostic/diagnosis DSMs for biomedical-database-dependent LOC 
systems with the help of computational modelling. 
With the rapid development of bioinformatics and so-called ‘big data’ technology, LOCs 
have also become attractive as biomedical information gathering tool by the 
bioinformatics branch.33 The third category of DSMs is just emerging and is still not 
completely developed; it relies on computational modelling within a large-scale 
medical/healthcare database. Fascinatingly, this class of LOCs is developed prior to the 
birth of the DSMs. The LOC devices will be first employed to collect sufficient clinical 
data as input of a relevant biomedical database; after that, predictive computational 
models will be built by classification techniques on the basis of the relevant database; 
finally, various prognostic or diagnosis DSMs are created for the LOCs to detect health 
risks and identify dangerous health trends. At present, the research activities on these 
biomedical-database-dependent LOC systems remain in the stage of prospective study. 
Undoubtedly, construction of relevant biomedical databases and the informatics research 
of data mining are arduous and time-consuming tasks to be undertaken before rendering 
these LOCs with prognostic/diagnosis functions. This category of LOCs generates both 
the tools to build their own supporting databases and to be the executive carriers of 
prognostic/diagnosis applications in the future. Compared with the previous two 
categories of DSM, this category has a longer development cycle, greater R&D 
investment and higher risks. Few researchers are willing to develop this kind of LOC, but 
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the author believes that the new-concept LOCs represent a promising development 
direction for the future. 
1.2 Typical biomedical applications of LOC technology. 
In considering the factors from both the technological and practical aspects, an 
application-oriented R&D strategy was chosen in this study and demonstrated in the 
following applications, leading to a series of relevant biomedical LOC devices with 
various DSMs. 
1.2.1 LOC applications in water quality monitoring. 
Inadequate access to clean water is hugely detrimental to both economic development 
and human health.34 In the developing world, 2,200 children die daily from diseases 
transmitted through unsafe water and 780 million people still lack access to safe water.35 
Great effort has been invested in keeping water clean and safe. However, outbreaks of 
water pollution incidents still threaten people in both developed and developing countries 
in spite of the advancements in water treatment technology.15 Industrial and 
environmental testing applications are always driven by the rollout of technology that can 
meet the increasing regulatory requirements and consumer demand for assuring food and 
water quality.36 However, sending samples to the lab and inspecting growths in petri 
dishes under a microscope a week later remains the standard reference for accuracy; 
companies of checkout equipment are increasingly also using faster microfluidics tests in 
house for more immediate feedback, and for ongoing monitoring and optimization of their 
control and treatment processes.36 
According to the different purposes, the methods and tools for monitoring water quality 
differ sharply. Close attention has been paid to two major application fields. One is the 
water safety of drinking water supply systems in modern cities, while the other concerns 
the environmental monitoring of natural water bodies. In addition, some special 
applications include water testing in swimming pools, water quality control of fisheries, 
the monitoring of wastewater, agricultural irrigation water, and the water supply to 
hospitals or biological laboratories etc. The different purposes of water quality testing 
determine the different standards, testing methods and tools. 
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The main purpose of environmental monitoring in natural water is to detect pollutions 
produced by human activities and to maintain ecological safety. Environmental 
monitoring has to be undertaken daily to deal with unpredictable events. As for general 
natural water, the ecosystem already exists there, and water quality testing mainly focuses 
on chemical contaminants, eutrophication, waterborne pathogens and ecological 
biomarkers etc. The research in this direction has a close relationship with hydrobiology 
and ecology. The degree of biological response ranges from a change in the molecular 
level of a single microorganism to the structure of a community and even to the function 
or structure of an ecosystem.37 However, environment-oriented LOC research will usually 
study microorganisms in the water. The polyurethane-foam-unit (PFU) method was 
established and has been standardized and widely used in China to evaluate the toxic 
effects of pollutants, in which protozoans are selected as ecological indicators.38,39 PFU 
blocks have to be exposed to an aquatic environment for several days before they recover 
and became subsequently enriched in living microorganisms.15 
Furthermore, another group of microorganisms in water always attracts the interest of 
LOC researchers, i.e. waterborne pathogens. The data from all over the world provide 
evidence that waterborne pathogens are responsible for acute poisonings and various 
diseases in animals, wild and domestic, and in humans.19 In Europe and North America, 
the direct-drinking water system is also vulnerable to waterborne pathogens (e.g. 
Escherichia coli, Legionella, Acanthamoeba, adenoviruses, rotavirus, etc. ), which calls 
for a strong aspiration to develop high sensitive monitoring system against waterborne 
pathogens, so as to ensure the safety of the drinking water system.19 
According to the website of World Health Organization (WHO), rotaviruses are estimated 
to be responsible for approximately 5 million deaths each year, with more than 85% of 
these deaths occurring in low-income countries in Africa and Asia, and over two million 
are hospitalized each year with pronounced dehydration.19 Children under five years of 
age, especially those between six months and two years, are most vulnerable to the 
disease.19,40,41  
Many LOC tools have been developed for monitoring these pathogens, which threaten 
public health not only in less developed villages, but also in modern cities. Tap water 
systems are always pivotal to public health in modern cities. Publicly available treated 
water has historically been associated with major increases in life expectancy and 
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improved public health, meanwhile water pollution accidents as well as some intentional 
contamination events in the municipal water system are also universal threats to urban 
residents.42 Monitoring for the presence of possible contaminants in tap water has led to 
a common need for early warning devices that can sensitively detect toxicant chemicals 
and waterborne pathogens in tap water within the early stages of contamination events. 
Actually, real-time evaluation devices for water quality have been widely studied for a 
long time. Owing to the water industry being highly developed, rare pollution events can 
threaten the water safety of the water system in a city.20  
However, dangerous factors still exist around the houses in the cities. In many cities, the 
sewage and water supply networks have been working for almost 100 years.20 
Exchanging the water supply network is often not frequent enough to ensure adequate 
water quality in all houses.20 Besides, drinking water and sewage pipes often have 
imperceptible leaks.20 The collapse of pipes causes interchange between drinking water 
and sewage, which can involve local pollutants in the drinking water supply.20 Although 
high-frequency examinations will increase the costs for domestic consumers, periodic 
inspection is essential in reducing the impact of hidden accidents.20 Moreover, the options 
of real-time analysis methods for a broad range of contaminants are still not flawless. The 
urban water supply systems require that the monitoring methods provide a rapid response; 
a real-time online testing system would be best, since every minute for an urban water 
system is of vital importance. 
In the event of accidents or intentional contamination, municipal water is susceptible to 
two kinds of contaminants, i.e. chemical or biological pollutants. The detection methods 
of chemical pollutants are very different from those for biological ones. Moreover, 
unknown contaminants are continuously being discovered, while detection methods at a 
low-concentration level in drinking water have only recently become available.43 The 
newly discovered pollutants will gradually turn into conventional ones over time. It is a 
fact that emerging contaminants are always present potentially evading the detection by 
the current real-time monitoring systems for municipal water, no matter how many test 
items are prepared in the real-time evaluating devices.44 
Security events in an urban water supply system are typically processed in three stages: 
1) Early warning stage: (to be conscious of an abnormality in the water.) 
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           2) Hazard identification stage: (to confirm the problem of water quality by 
accredited methods.) 
           3) Crisis solving stage; (to solve the public crisis in the correct way) 
 
The first two stages depend on varied methods of water quality detection, whereas Stage 
3 is outside the scope of this Chapter. In Stage 2, current qualitative/quantitative detection 
methods are sophisticated for most pollutants. However, perfect technology for Stage 1 
is still missing. Due to the lack of ideal wide-range online detectors, regular sampling and 
laboratory-based technique still dominates the work in Stage 1, but Stage 1 is the most 
important phase. The earlier contamination is found in water, the lower the loss caused 
by the pollution. At present, online monitoring equipment for water quality (MEWQ) is 
often expensive, and the measuring range or sensitivity has to be further improved.45 
MEWQ has been highly developed and commercialized, varying from bench-top 
precision equipment to mobile quantitative early warning monitors (Figure 7). 
From the engineering point of view, the ideal solution is to merge the first two stages. 
That is, to design an ideal detector capable of continuously accurately measuring water 
quality parameters and to transmit real-time measurement results over long distances. 
Currently laboratory automation technology is sufficient for the tasks of detecting 
conventional parameters such as pH, redox potential, free available chlorine, conductivity, 
turbidity, etc.46 At the same time, telecommunication technology is also advanced enough 
to support the function of remote real-time monitoring. However, the major barrier here 
is the high maintenance costs of online MEWQ in the waiting period of Stage 1. Typically, 
water quality has to be examined frequently to guarantee public water safety, since 
unpredictable water pollution accidents break out infrequently. However, the price for 
any kind of accurate measurement is always not cost-efficient, let alone a group of 
accurate measuring experiments used to exclude the presence of a variety of known 
pollutants. Thereupon, the maintenance cost will be considerably high. The expensive 
online quantitative methods and tools are only suitable for the pivotal of water supply 
network in a city. Furthermore, the measuring frequency will be actually reduced to 
control the maintenance cost in the waiting period of Stage 1, resulting in the risk of some 
rapid contaminant events during the measuring intervals. Another problem is that those 
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expensive online detectors can only cover the central part of the water supply network, 
instead of sub-pipelines and end branches. 
Another strategy for water quality monitoring is to totally separate the purposes and 
methods between Stage 1 and Stage 2. That is, to use a low-cost long-term broad-
spectrum online MEWQ for Stage 1, and to involve those expensive precision instruments 
and accurate methods for Stage 2 after triggering the alarms in Stage 1. This strategy 
could satisfy both respects from the security requirement on drinking water and the 
maintaining costs of the surveillance system. In fact, the major task for the online MEWQ 
in Stage 1 is the timely and correct discovery of the abnormality in the water, instead of 
accurate qualitative measurement. 
The automation equipment can simplify or replace manual operations. Unfortunately, 
most of them are designed for Stage 2, whereas tools for Stage 1 are relatively insufficient, 
though many detectors are claimed to be real-time, online, and sufficiently low-cost. As 
implied by the product descriptions, these online water quality monitoring systems cannot 
monitor all kinds of specific contaminants directly, because monitoring of many different 
specific contaminants is currently not feasible.45 Instead, research shows that many 
contaminants affect one or more water quality parameters such as chlorine residual, TOC, 
pH, conductivity, etc.45,47 Therefore, current online MEWQ with the detecting capability 
of limited water quality parameters also has a potential to detect contaminants.45 Although 
those devices have been quite advanced already, no suitable online MEWQ could be a 
perfect solution in meeting the high demand for safety and efficiency at a relative low 
expense. 
LOC technology is probably a low-cost solution for MEWQ, because it is possible to 
reduce the reagent and energy consumption by miniaturization. With reference to 
numerous multiphase separation and multistep reactions, LOC technology is well suited 
for the implementation of complex reactions for biomedical detection. 
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Figure 7. Commercialized automatic instruments for water quality monitoring.45,48-
57 (a) YSI™ 5100 BOD laboratory setup (laboratory analysis for Biochemical Oxygen 
Demand/BOD, dissolved oxygen, pH, etc.).48 (b) Hach™ eclox rapid response water test 
kit (parameters: chemiluminescence toxicity screening, arsenic, pesticide/nerve agents, 
chlorine, colour, total dissolved solids, pH).49 (c) YSI™ 556 MPS (Multiprobe System) 
combines the versatility of an easy-to-use, easy-to-read handheld unit with all the 
functionality of a multiparameter system (dissolved oxygen, pH, conductivity, 
temperature, etc.).50 (d) An online water quality monitoring system installed at a military 
facility.45 (e) s::can™ Messtechnik GmbH, Submersible UV-VIS-spectrometer probe 
installed in a spring chamber. (Parameters: turbidity, SAC254, Nitrate, Total Organic 
Carbon/TOC, temperature and electric conductivity).51 (f) Colifast ALARM™ (At-line 
automated remote monitor) detects total coliforms, thermotolerant coliforms or E.coli in 
drinking water. The fully automated system consists of an analysing instrument and a 
bacterial growth medium system. In addition, the Colifast ALARM can measure the 
turbidity level of the water.52 (g) ADASA™ mobile stations for water quality 
monitoring.53 (h) GE™ Sievers InnovOx® on-Line TOC analyser provides industry-
leading sample handling robustness and instrument uptime for process, environmental, 
and wastewater TOC Analysis.54 Typically, it can run 30 days without replacing 
reagents.54 (i) A multiparameter water quality system for water quality monitoring 
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provides one of the most efficient solutions for the continuous on-line measurement of 
pH, Oxidation-Reduction Potential/ORP, conductivity, temperature, free chlorine, total 
chlorine, monochloramine, and oxygen.55 (j) Q45WQ water quality panel (Analytical 
Technology™, Inc., USA) provides constant, on-line monitoring of any remaining 
disinfectant and up to 6 other parameters in water distribution systems and moveable 
water treatment facilities.56 (k) The AppliTOX® on-line broadband toxicity analyzer is a 
fully automated batch bioassay based on the well-established ISO 11348 laboratory 
procedure. The original test protocol has been used since the 1980s and is accepted as a 
standard method in a large number of countries and applications.57 
1.2.1.1 LOC technology for microbial detection. 
Evaluation of microbes in water can protect people from illness due to consumption of 
water containing pathogens, thus prevent the outbreak of water related diseases.13 Most 
current procedures for microbial analysis in water monitoring are based on periodic 
sampling and culture methods, which are slow, requiring 24–48 h. When the first results 
reach the decision-takers and trigger an alarm, significant time has already passed and the 
population may have been exposed to a health hazard.58 There is a need for rapid, reliable 
detection of microbial contaminants.58 
As a primary laboratorial method for microbial analysis, culture methods have a variety 
of drawbacks, though this method is probably the most authoritative. To monitor 
waterborne pathogens with high efficiency, immunoassay methods are widely used.19 
Besides, relevant researchers have increasingly moved toward molecular technologies to 
meet the need for rapid, multiplexed, species-level detection, ranging from PCR, NASBA 
to microarrays.58,59 Based on the principle of PCR amplification, some isothermal 
DNA/RNA amplification assays have been developed, including loop-mediated 
isothermal amplification,19 T7 based linear amplification60, NASBA, etc. NASBA has 
been directly realized in waterborne pathogen detection,61 which requires a procedure of 
extracting the mRNA from the sample.19,62 However, the immunoassay methods, such as 
ELISA (enzyme-linked immunosorbent assay), can avoid the extraction of DNA or 
mRNA, making the original signal of microbes easier to be quantified.19 Among the most 
common detection methods, immuno-PCR assay with femtomolar sensitivity and high 
specificity is the most sensitive, combining the advantages of both immunoassay and 
PCR.19,63-67 Combined immunoassay and NASBA, IMRAMP (immuno-real-time-
amplification) is also highly sensitive, with sensitivity at least 103 to 105 fold higher than 
the ELISA technology19,68,69, shown in Figure 8. 
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Figure 8. Amplification mechanism of IMRAMP (immuno-NASBA) assay.19 
Reproduced from Ref. 19 with permission from the Royal Society of Chemistry. The 
principle can be simply understood as immunoassay followed by NASBA amplification. 
The immunoassay is like a sandwich ELISA, but its report group is a barcode DNA with 
a T7 RNA polymerase promoter, not an enzyme. The barcode DNA plays a role as a 
bridge to connect immunoassay and NASBA amplification. After the NASBA 
amplification, the weak immune signals are enlarged by a million times and above. 
Eventually, fluorescent signals are released with the help of beacon probes.19 
Furthermore, various methods for biological detection have been developed. For example, 
the ATP bioluminescence assay (ATP-BLA) is a multistep process involving the luciferase 
enzyme, luciferin substrate, oxygen, magnesium cation and adenosine triphosphate (ATP), 
which will induce the efficient emission of photons (550-570 nm).70-72  
In fact, most biological methods rely on the optical properties of analytes, including light-
scattering detection,73 enzymatic fluorescence detection,74 chemiluminescence 
methods,74 electrochemiluminescence detection,75 Raman spectroscopy,76 dye-loaded 
microsphere detection,77 etc.58,78 These existing methods enable the quantification of very 
low concentrations of microbes with high specificity.58 Generally, limit of detection (LOD) 
of the methods without molecular amplification could only reach the level of 1×103 
cells/mL of analytes in the water samples.58 Unusually, the LOD of ATP-BLA could be 
up to the level of 200 cells/mL.58 When the methods contain a molecular amplification 
stage, the LOD could reach 1 cell/mL or even a lower level.79  
Detection of microorganisms at very low concentrations is still a challenge, especially 
aiming for online monitoring.58 Accordingly, current microbial detection mainly relies 
upon intermittent biological methods, while continuous broad-spectrum methods and 
tools for monitoring microbes are still insufficient. Of course, increasing the frequency of 
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intermittent experiments, and implement broad-spectrum detection by using high-
throughput biochips will be a solution for online monitoring of waterborne pathogens, but 
testing costs would increase dramatically. Moreover, high-throughput biochips still 
cannot solve the detection problem of unknown pathogens in water. 
In fact, various LOC devices for monitoring of pathogens have been widely studied.20,80,81 
Taguchi et al. investigated an immune-capture LOC device to trap protozoa for 
subsequent fluorescence tests.82 By using this concentration tool, 10mL of a sample 
mixture of 107 oocysts/mL could be simply captured on the chip within 1 h.82 
Dielectrophoretic (DEP) LOC is another method of concentrating pathogen samples, and 
DEP LOCs for environmental microorganisms have been reported.83 Some concentration 
factors in these applications could achieve 104-105.34 Subramanian et al. reported an 
immunological LOC based on the principle of surface plasmon resonance for detection 
of E. coli O157:H7 with a LOD of 104-106 cells/mL,84 inferior to those of ELISA LOCs.85 
It is worth noting that molecular-biology-based microarray technology has become a 
standard high-throughput method for the screening of pathogens. Wong C. et al. have 
developed a DNA chip that can identify 70,000 different viruses and bacteria in one 
test.6,86 
Cell-based LOC is another important branch for microbial detection.87 The usage of 
LOCs could result in better environmental control over cells or bacteria during cell 
culturing. At present, the invention of ‘organ-on-a-chip’ could lead to improvement in 
traditional culture-based pathogen-monitoring approaches.34,88 LOCs might also allow 
the design of micro-environment to promote the culture of microorganisms, which are not 
yet achieved in a standard biological lab. 
At last, one of key factors to commercialization for applied-oriented LOCs is faster and 
easier fabrication.20 Sometimes, the cost of a LOC is more attractive than its precision of 
measurement.20 Moreover, LOCs in this field are often disposable chips, therefore 
expensive and time-consuming fabrication methods are naturally excluded.20 
1.2.1.2 LOC technology for monitoring chemical contaminations. 
A huge market for water quality monitoring always exists. The global market for drinking 
water reached EUR 250 billion in 2008, with investment of over EUR 33 billion per 
annum.89 For decades, researchers have placed great importance on the detection of 
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chemical pollutants; hundreds of accurate MEWQs have been commercialized for 
chemical analysis. Therefore, developing LOCs to measure chemicals in water accurately 
seems not very demanding, but LOCs for early warning of chemical contaminations in 
water are still promising. 
Most commercial online MEWQs are relatively expensive (Figure 7). In addition, these 
MEWQs (e.g. Figure 7, insets D, G, I and J) are strongly dependent on the model and 
optimization software to deduce some typical contamination events, however many 
atypical events are often neglected. Existing systems employing living cells (e.g. Figure 
7, inset F) are often impractical in size or involves sample preparation. Miniaturization of 
the above-mentioned system could probably result in the reduction of system costs. LOC 
technology has provided the possibility to miniaturize the instruments. Based on the LOC 
structural frame, the ideal early warning devices for water quality should fulfil the 
following conditions: 
1) Have a low maintenance cost; 
2) Be able to work continuously online; 
3) Be able to monitor a broad range of harmful chemicals over a threshold of 
sensitivity and accuracy for the guarantee of timely and correct alarms; 
 
The main purpose of an early warning device for water quality is not to quantify the 
accuracy parameters in water. Instead, qualitative diagnosis is sufficient. The most critical 
challenge is how to make an early warning system with a broad-spectrum detection range 
able to work continuously at a low cost. Notably, the early warning devices cannot replace 
the existing MEWQs for accurate analysis. They are compatible with the existing system. 
Electrochemical sensors are the most popular tools for online detection of specific 
chemicals in water, because they can real-time measure specific chemicals continuously 
at a low cost. However, the sensitivity of electrochemical sensors could be a challenge, 
particularly in highly purified drinking water, since water quality standards for drinking 
water in most developed countries are often close to the LOD for ordinary electrochemical 
sensors.46 Moreover, the electrochemical principle is for specific chemicals, instead of a 
naturally broad-spectrum method. Most MEWQs in Figure 7 are composed of 
electrochemical sensors, each of which is only able to measure a specific parameter. 
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Another frequent online warning method for detecting chemicals is the spectrometric 
method, which has also been commercialized, for example, in Figure 7, inset E. That tool 
can continuously work in theory, because the maintenance cost of spectrometric 
measurement mainly lies in the consumption of light sources and lens smearing. At 
present, these tools are mainly employed in the monitoring of sewage discharging into 
the aquatic environment, instead of quality tests for drinking water. Unlike 
electrochemical sensors, spectrometric ones could be natural broad-spectrum for organic 
compounds. However, a precise optical instrument often requires a high maintenance cost 
to keep working in the field. 
In fact, biological sensors have obvious advantages in the early warning of chemicals. 
When using a living organism as the core sensor to judge the presence of chemical 
contaminants, the living organism is the natural authority and has an innate broad range 
of detection. Besides, the maintenance cost for the survival of the living organisms is not 
very high. Living organisms can evaluate the total toxicity of aqueous samples, instead 
of concentrations of specific chemical constituents.13,21 For example, the Toxprotect™ 
fish monitor (GmbH, Schwentinental, Germany) was developed to detect toxins in water 
by analysing the swimming activity of fishes.90 If the fish in a river shows anomalies, it 
is an indication for toxins in the water.21 
However, animal models have a high resistance to varied factors and are the subject of 
some ethical issues. Cell-based toxicity tests provide an alternative to animal 
experiments.21 These systems can monitor a broad range of chemicals, including some 
unknown chemicals.21,91 Model mammalian or human cells display similar physiological 
responses to the cells in the human body; however, it is difficult to maintain the viability 
of mammalian cells.21,92 Bioluminescent bacteria have a higher growth rate, and are less 
costly to propagate, and easy to detect.21,93 Thus, bioluminescent bacteria represent 
promising sensors for use in continuous-sensing devices against toxicants.21 Specially, 
the light-emission ability of the natural marine bacterium Vibrio fischeri was widely 
employed in sensitive and rapid luminescence-based tests, described in ISO 11384.21,94-96 
The living-organism system can be easily disturbed by various factors, so the 
standardization of living organisms should be treated as a serious requirement. For 
example, the experimental method of ISO11384 employs a periodic standardized 
procedure to solve the challenge. V. fischeri luminesces through the production of 
X. Zhao: Application-oriented microfluidic LOC devices for the detection of microorganisms, toxic chemicals and serological biomarkers 
25 
 
luciferase, which catalyses the oxidation of a long-chain aliphatic aldehyde (RCHO) and 
a reduced flavin mononucleotide (FMNH2).21,94 The free energy in this reaction is 
released in the form of light at a wavelength of 490 nm:21 
FMNH2 + RCHO + O2 → FMN + RCOOH + H2O + hγ (490 nm) 
The presence of acute toxicants that affect this reaction can suppress or extinguish the 
light emission.21 The method has been widely used in the rapid qualitative assessment of 
water quality. 
Furthermore, it was also used in a few automatic systems, storing standard copies of 
lyophilized V. fischeri cells. Periodically, the automatic system will use one copy in each 
individual test for water quality. The DSM of such kind of automatic systems is a typical 
conventional one. The design is not very suitable for continuous early warning of water 
quality, because there are long intervals between the adjacent intermittent tests. Given 
sufficient conditions, such an instrument could be miniaturized into a LOC, but it may 
not be necessary. Actually, promising alternative solutions have emerged. 
A new branch of LOC, ‘integrative biology’ technology, casts a hopeful ray on the cell-
based early warning device of water safety. This solution integrates the living cells21,97,98 
or small tissues99-101 or organoids102-104 into a LOC device, which turns into a chimeric 
long-term working device with ‘life’, including cell-based LOCs in the early years, 
microfluidic cell and culture systems or body-on-chip or tissue-on-a-chip, or organ-on-a-
chip in recent years. In theory, this type of LOC is promising in solving the above-
mentioned challenge in the field of early warning of water quality, because not only the 
living ‘component’ on the chip retains a broad detection band, but also the LOC structure 
limits the independent variables. The integrative LOC could probably generate an explicit 
output signal, compared with the present devices. However, the DSMs of new integrative 
LOCs have to be determined by the design of LOC systems, which belongs to typical 
unconventional DSMs. 
1.2.2 LOC applications in medical diagnosis and treatment 
Medical diagnosis is another typical field for LOC applications. The LOCs, called 
‘sample-to-answer’ systems, are able to perform fast and low-cost tests on small volumes 
of biological samples and to seek for diagnostic conclusions,.23 Over the past few decades, 
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research has been conducted in this field to detect patterns of biomarkers and provide 
information on their concentration in biological samples for robust diagnosis. In fact, the 
working principles and basic structure of the LOCs in the medical field are quite similar 
to those LOCs designed for water quality monitoring. Especially in pathogen detection, 
the methods of quantifying microbes in human urine or blood samples are almost the 
same as those of waterborne pathogens, demonstrated in Chapter 1.2.1. 
However, due to their different purpose and sample properties, two cohorts of LOCs are 
not exactly the same. For medical detection, the biological samples e.g. urine, blood etc. 
are usually more complex than water samples. Consequently, the challenges in the sample 
treatment of medical LOCs are much larger than LOCs in the cases of water quality 
detection. On the other hand, medical LOCs are clearly biased towards the function of 
rapid in-situ detection, whereas the LOCs for water quality detection aim at continuous 
online working over a long period. The most common types of commercial LOC in the 
medical field are lateral flow devices, i.e. dipsticks or strips.(Figure 9) Lateral flow 
devices embody all the characteristics of medical LOCs. They are small, portable, easy-
to-use, cheap and disposable. In addition, the turnaround time of strips has been shortened 
into several minutes. Their unique drawbacks lie in the measurement precision. Usually, 
lateral flow devices are used as widespread qualitative tools for medical screening. 
 
Figure 9. Schematic mechanism of a lateral flow device.105 The LOC is based on 
immuno- or antibody-based test. It is often comprised of a nitrocellulose membrane 
covered by a sample pad on one end and a wicking pad on the other end. The sample pad 
will be submersed in a sample solution, e.g. urine, blood, etc. The solution wicks up the 
nitrocellulose membrane on the strip, causing the fluid to pass over an area containing an 
excess of gold-labelled detector antibody specific to the target protein. After that, the 
antibody-protein complex will continue moving up the strip with the flow of fluid. When 
the gold-labelled antibodies with bound proteins pass over the test line, the antibody-
protein complex forms a sandwich with the immobilized capture antibody. This results in 
the formation of a visible line on the strip indicates that the target protein is present in the 
sample.105 
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The field of medical LOCs has been well-reviewed, though it is still a research hotspot 
for researchers and companies, shown in Figures 3 and 4. Recent reviews are good 
reference materials for a general overview of medical LOCs.106-111  
It is not necessary to duplicate the similar work in this PhD thesis. Here, we only discuss 
several frequent but critical questions about the study of medical LOCs. 
1) Why do current medical systems need LOCs? 
Excitingly, the modern medical system has established a complete laboratorial 
methodology for medical diagnosis, which is able to handle almost all kinds of medical 
cases. Except for emergent cases, sending the sample to the lab and inspecting the growth 
in a petri dish under a microscope within a week remains the acceptable standard 
reference in the medical field. However, LOCs could reduce the turnaround time of 
medical tests in house or in the screening stage for more immediate feedback, which will 
be beneficial to patients in avoiding unwanted medical examination and optimizing the 
treatment processes. Medical LOCs are able to undertake these diagnostic and screening 
tests out of the lab and direct at the point of care. However, advanced LOCs are still 
significantly expensive, so the established system of laboratorial tests still maintains its 
entrenched status. From the point of view of DSMs, the risk-adverse medical system still 
trusts in the accuracy of the traditional laboratory tests, more than the faster LOCs with 
new DSMs. LOCs have started to make inroads in emergency rooms, particularly for 
diagnosing cardiac events and identifying the bacteria causing severe infections, where 
saving time saves lives.36 
2) Which application fields are medical LOCs well suited for? 
Demand for LOC devices for research in pharmaceuticals, life sciences and medical 
sciences is increasing strongly. As the research moves to more complex biological 
analysis, traditional laboratorial tests have switched to high-throughput automatic 
processing. LOC is a perfect platform to implement high throughput biomedical tests. In 
particular, medical LOCs are suited for handling experiments into living cells or 
biological samples, since researchers always intend to understand the underlying 
processes of the body response on the cellular level, which needs more complex high-
density chips with thousands of reaction chambers and high precision structures.36 
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3) What are the most commonly used biological samples for medical LOCs? 
Since medical LOCs are good at performing multiphase multistep biochemical reactions, 
the most commonly used biological samples are various body fluids, including blood, 
urine, saliva etc. In the daily work of a hospital, urinalysis and blood tests may be the 
most common options for biochemical examinations. LOC researchers are also interested 
in these demanding fields. 
First, urine is an abundant bio-fluid that can be readily obtained by convenient means.112 
As the wastes of the bloodstream extracted by the kidneys, urine contains high 
concentrations of urea, inorganic salts, creatinine, ammonia, organic acids, various water-
soluble toxins and pigmented products of haemoglobin breakdown.113 Nowadays, 
urinalysis methods are mainly used in labs and hospitals, mostly including physical 
urinalysis tests, microscopic examinations and chemical assays.114 The advantages of 
urinalysis mainly lie in its non-invasiveness and high sensitivity. The results of urinalysis 
could be employed to detect personal health changes at an early stage.115 Compared with 
blood sampling processes, the sampling of urine is much easier and can be repeatable in 
a single day. Medical studies have been carried out to prove the correlation between 
urinary components and respective human diseases, such as diabetes, kidney diseases, 
UTIs etc.114 Besides, urinary metabolomics or urinary proteome is a perspective method 
for diagnosis, especially appropriate for kidney cancers and chronic inflammatory 
diseases.116,117 The results of urine tests can also reflect some toxicological or metabolic 
responses of the body, because metabolites and proteins in the urine mainly come from 
plasma proteins.118 In the current study of proteome, urine has shown some unique 
advantages so it is considered to be a suitable source for both physiological research and 
disease biomarker discovery. Some changes in the plasma proteome may be distinctively 
reflected in urine, the waste of the human body, whereas those changes may be concealed 
by the steady state inside the body.119 Many studies have been undertaken in the field of 
urinary metabolomics and proteomics.113,119 More than 2600 metabolite species and at 
least 1500 proteins have been found in human urine, among which considerable 
associations to human diseases were discovered, such as UTI, bladder cancer, diabetes, 
etc.113,119,120 
The study and analysis of human urine was the starting point for laboratory medicine in 
the history. At present, urinalysis is generally adopted by hospitals, and actually, it is also 
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suitable for monitoring daily health conditions at home. Urinalysis devices are widely 
available for chemical examinations in hospitals, such as chemical auto-analysers etc. The 
microscopic examination is another class of traditional urinalysis methods. Becoming 
more intelligent and automatic, current urinalysis tests rely more and more on automatic 
instruments. The emergence of automatic urinalysis instruments can not only offer the 
opportunity to standardize the microscopic and chemical examinations of urine samples, 
but also reduce the operating error, the labour intensity and the operation time of 
urinalysis.121 The urinalysis system for home users has aroused general interest among 
researchers, since urine tests are suitable for the household daily monitoring of personal 
health conditions. Obviously, urinalysis LOCs are logical solutions for this purpose, but 
inadequate importance has been placed on urinalysis LOCs, due to the lack of developed 
DSMs. The knowledge of urinary diagnostics is accumulating in line with the 
development of urinalysis tools, including LOCs. 
Second, blood testing is another common technique used in hospitals, with detection in a 
single test typically ranging from several items to tens of biomarkers. Since blood belongs 
to the internal environment of the human body, its importance in medical diagnosis is 
beyond any doubt. Compared with urine, blood samples have high stability in a normal 
person. When the composition of blood changes dramatically, great changes may occur 
inside the human body. Owing to decades of medical research, doctors and scientists have 
discovered profuse knowledge of blood diagnostics, which becomes conventional DSMs 
for LOCs of blood tests. 
However, blood contains unknown knowledge which needs to be discovered, accordingly 
more developing DSMs for blood test LOCs will emerge in theory.122 At present, around 
four hundred types of signal molecules in the blood stream are known, whereas the most 
commonly referenced in a hospital is less than fifty.22 Although the concentrations of 
signal molecules are extremely low, signal molecules are important to maintain routine 
functions of human bodies. Signal molecular profiling (SMP) can provide holographic 
data of the entire human body.18 SMP is related not only to human gene mapping, but also 
to the interactions between the human body and the surroundinenvironment.18,123 In most 
cases, dramatic changes of SMP indicate the advent of disease (e.g., cardiovascular 
disease, cancer and invasion of pathogens).18,124 Although much effort has been made to 
discover the diagnostic relationships between serological biomarkers and their respective 
diseases, the progress is hampered by the absence of a high-capacity clinical database on 
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human serological information.18 Only a small proportion of such diagnostic knowledge 
has been uncovered.125 In fact, the network of signal molecules has a well-ordered 
structure.18,126-128 Translational relationships between signal molecules and specific 
diseases are more complex than those in physiology or pathology.18  
To build such a medical database, high-throughput serological tests are required to use 
high throughput tools, e.g. microarrays. SMP records will be good resources for data 
mining in the field of translational bioinformatics (TBI). The hidden information behind 
the SMP data will be discovered for better understanding of physical conditions of 
individual patients in the future.18 
Current protein microarrays are too expensive as the practical tools for SMP data 
acquisition.22 They are often built on a flat glass slide or matrix-based material. The 
reaction interface on the slide might be easily smeared when manipulated carelessly; due 
to the slow speed of molecular diffusion, complete bio-hybridization assays usually 
require several hours, or even a couple of days. The demand of the SMP study calls for 
specific low-cost high-throughput LOCs, which DSMs are typically within the category 
of developing ones. In Articles V and VI, the study on SMP and the related LOCs were 
reported. 
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1.3 Aims and tasks. 
In this thesis, the researcher aims to solve three specific practical problems in various 
cases by using LOC technology, including water quality detection, UTI diagnosis and 
serological study. A methodological study of LOC systems is also demanded during the 
R&D of various LOCs. The main objectives were shown as follows: 
 Aim 1: To evaluate water quality by using LOC technology at a low cost, 
especially in the drinking water system. 
Task 1: To design and realize a disposable sensitive LOC for qualitative or semi-
quantitative detection of multiple microorganisms in water at the same time. In 
addition, the LOC should be compatible with a cost-efficient or common laboratory 
instrument to reduce the system cost. 
Task 2: To implement a high-throughput LOC for precise quantification of 
microorganisms in water, and design the sampling module with seamless connection 
to the LOC. Similarly, the LOC should also be a compatible component to the cost-
efficient or common laboratory instrument in Task 1. 
Task 3: To develop a cost-efficient continuous LOC system for long-term monitoring 
of a broad-spectrum of toxic chemicals in water. 
 Aim 2: To evaluate physical conditions or prognosticate diseases through a simple 
serological test by using LOC technology. 
Task 4: To realize high-throughput quantification of signal molecules in serum by 
using a simple low-cost LOC, and design a roadmap for building a relevant 
biomedical database to support its diagnosis or prognosis functions of the LOC. 
 Aim 3: To efficiently identify pathogen types and their antibiotic resistance 
properties in the diagnosis and treatment of UTIs. 
Task 5: To design and validate a disposable high-throughput LOC for detection of 
microbial pathogens in a bacteriuria sample and further investigation of antibiotic 
resistance properties of the microbes. Similarly, the LOC should be compatible with 
the cost-efficient or common laboratory instrument in Task 1. 
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1.4 Contributions of the thesis. 
The research tasks have been fulfilled in association with the primary supervisor, who 
provided the primitive ideas in the study. The chip design and system integration was 
mainly undertaken by the candidate under the guidance of the primary supervisor, but a 
part of chip fabrication was processed with the help of SINFEF™ MiNaLab, Xiamen 
University(XMU, China) and Nanjing University of Science and Technology (NUST, 
China). The experimental installation and validation was also performed by the candidate 
with the laboratorial resources in the partner institutes, including Institute of 
Hydrobiology at Chinese Academy of Sciences (IHB-CAS, China), XMU, NUST, 
Chongqing Technology and Business University (CTBU, China), Ziyang Maternal and 
Child Health Hospital (ZMCHH, China) and Chongqing Xiji Hospital (CXH, China). The 
candidate conducted the entire work of data acquisition and analysis. Thanks to the 
comprehensive contacts of the primary supervisor, my doctoral work could obtain so 
many interdisciplinary resources from the above-mentioned partners. 
The main scientific contributions of this doctoral work are as follows: 
1. The invention of a series of disposable LOCs to be compatible with standard 
microplate readers in common biological laboratories, serving as a low-cost 
model for other LOC systems; 
2. The development of V. fischeri cell-based LOCs for continuous early warning of 
chemical toxicants in water; especially, the invention of the cell-based LOC with 
a coral-reef bioreactor. (unpublished) 
3. The realization of sensitive and complicated immuno-NASBA and Q-NASBA 
assays on microfluidic LOCs, with the development of a novel analytical 
algorithmic method for NASBA-based quantification tests. 
4. The development of a microfluidic LOC of Immunosorbent ATP-bioluminescence 
Assay (IATP-BLA) for rapid pathogen identification and antimicrobial 
susceptibility testing (AST) in the diagnosis of UTIs, as a good model of 
microfluidic simulators for medical diagnosis and treatment. 
5. The development of low-cost LOCs, named ‘SMP chips’, for simultaneous 
quantification of hundreds of signal molecules in blood. Based on the SMP chips, 
the construction roadmap of the human signal-molecule-profiling database 
(HSMPD) is also studied. 
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6. The concept of ‘decision support mechanism’ (DSM) is proposed for the R&D of 
application-oriented LOC devices. Moreover, three categories of DSM for 
application-oriented LOCs are demonstrated for the first time, including 
conventional DSMs, unconventional DSMs and developing prognostic DSMs. 
Most research achievements have been reported in international scientific publications. 
Furthermore, a summary of these scientific discoveries is presented in Chapter 2. The 
candidate prepared all manuscripts with the revision by the co-authors. 
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2 Summary of the articles 
This chapter presents six articles capturing the research contributions of this doctoral 
thesis. This doctoral work involved with two primary fields of application: 1) water 
research, reported in Articles I, II and IV; and 2) medical diagnosis, reported in Articles 
III, V and VI. The research in each article is application-oriented, with the result that each 
portion of the work was focused on a different application with a different background 
and different objectives. Although each article is relatively independent, together they 
have generated a common body of knowledge of LOC. In particular, the DSMs for these 
application-oriented LOCs can be categorized as shown in Table 1. The collected articles 
were organized according to their DSM categories, rather than their publication dates. 
 
Table 1: The categories of DSMs and LOCs in this doctoral work. 
 
 
Characteristics of 
LOCs 
Decision support mechanism (DSM) 
1) Conventional 
DSM 
2) Unconventional 
DSM 
3) Developing 
prognostic DSM 
Articles I, II and III Article IV Articles V and VI 
High-density chip Yes × Yes 
Disposable chip Yes × Yes 
Able to work 
continuously 
× Yes × 
Able to perform 
complicated tests 
Yes Yes Yes 
Application field 
/objectives 
Microbial detection 
Monitoring of toxic 
chemicals in 
drinking water 
Medical diagnosis, 
e.g., from blood 
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2.1 Functional LOC devices with conventional DSMs. 
The overwhelming majority of biomedical LOC devices rely on existing diagnostic 
mechanisms in laboratories, which may reduce the validation difficulty of new LOC tools. 
This strategy avoids unnecessary investigations of the working principles and diagnostic 
criteria. However, the degrees of freedom in the system design will be limited by 
conventional laboratory methods. 
2.1.1 Compatible immuno-NASBA LOC device for quantitative 
detection of waterborne pathogens. 
 Background 
See also Chapter 1.2.1.1 
 Objectives: (Article I) 
To develop a disposable sensitive LOC with a friendly reusable supporting instrument for 
the parallel detection of multiple microbial pathogens in water. 
 Main relevant projects: 
o FoU-forprosjekt i VRI Fund (Immuno-NASBA kretser, Project No.: 
38043) 
o Oslofjord Fund (Real-time quantitative IMRAMP microfluidic system, 
Project No.: 202444); 
 Challenges: 
o Is it possible to use existing equipment in a common biomedical laboratory 
as a low-cost reusable supporting platform for the disposable LOCs? 
o How can the LOD of the low-cost LOC system be improved? 
o How can parallel detection of multiple targets be implemented on a low-
cost LOC? 
 Design of the LOC system and its DSM: 
Common microplate readers present in standard biological laboratories were selected as 
the low-cost reusable supporting platform for the disposable LOC, entitled ‘immuno-
NASBA LOC’. It is modelled on a 96-well ELISA microplate (Figure 10).19 The 
prototype LOC has 43 chambers available to perform independent assays to 
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simultaneously monitor up to six targets in one water sample. Compatibility between new 
LOCs and mature detection devices could significantly reduce the R&D challenge. The 
most remarkable feature of this immuno-NASBA LOC is its compatibility with 
microplate readers, allowing users to avoid purchasing any additional equipment or 
analytical software for the new LOCs.19 
 
Figure 10. Architecture of the compatible immuno-NASBA chips.19 Reproduced 
from Ref. 19 with permission from the Royal Society of Chemistry. This prototype 6-
channel immuno-NASBA chip was designed and fabricated according to the dimensions 
of standard 96-well microtiter plates. It is composed of a polymethyl methacrylate 
(PMMA) plate and a transparent cover, see also Article I.19 
The DSM of the immuno-NASBA LOC is based on IMRAMP as described in Figure 8. 
The principle of this technique is close to that of the traditional ELISA assay. At first, 
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different capture antibodies are used to recognize different biological targets in each 
chamber. Then, the signals are amplified by follow-up NASBA assays prior to direct 
detection on a microplate reader as the LOC has the same dimensions as a 96-well 
microtiter plate. The external valve system is shown in Figure 11. It is used to carry out 
parallel reactions in the LOC.19 
 
Figure 11. Reusable valve and pump system for immuno-NASBA LOC.19 
Reproduced from Ref. 19 with permission from the Royal Society of Chemistry. Inset (a) 
depicts Package A for chip pre-treatment. Antibody reagents can be loaded into the 
tapered ports by using a pipette. Inset (b) shows Package B for the detection assay, see 
also Article I.19 
The IMRAMP assay has been almost shelved for many years. An important reason is its 
complicated protocol, whereas this LOC device can semi-automatically perform multiple 
protocols of the IMRAMP assay.19 The LOCs were made of PMMA, a common 
inexpensive material, so it is feasible for efficient production of the LOCs by multiple 
methods such as laser ablation, hot embossing or injection moulding technology. 
 Experiments: 
A series of antigen-antibody reactions were used to test the performance of the LOC 
prototype. The two common waterborne pathogens, Escherichia coli (E.coli) and 
rotavirus were used as the testing targets, while a peptide, adrenocorticotropic hormone 
(ACTH) was selected as a reference target. ACTH, E.coli cells and inactivated rotavirus 
were serially diluted in PBS buffer. Moreover, the 5×10-13mol.L-1 ACTH solution was 
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used as the ‘ACTH sample’ in the experiment. The 1.2×106 cells/mL (equivalent to 2×10-
15 mol.L-1) E.coli solution was prepared as the ‘E.coli sample’.19 The 1×10-2 µg/ml 
rotavirus solution was employed as the ‘rotavirus sample’.19 Three types of multiplex 
samples were also prepared.19 The schematic protocol is depicted in Figure 12.19 (See also 
Article I)  
 
Figure 12. The schematic protocol of the on-chip IMRAMP assay. Reproduced from 
Ref. 19 with permission from the Royal Society of Chemistry. (See also Article I for the 
manipulation details)19 
The tests used polyclonal antibody sera against E.coli and rotavirus; a pair of monoclonal 
antibodies with high affinity to ACTH were chosen for the detection of ACTH. The on-
chip IMRAMP assay is initialized on the surface of the PMMA inside the reaction 
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chamber. All reagents are prepared from DEPC-treated water. Diethyl pyrocarbonate 
(DEPC) was obtained from Sigma©.19 Barcode DNA was purified and biotinylated from 
the PreTectTM HPV-Proofer kit (Norchip©). The positive amplification product for HPV 
subtype 16 contained a large number of DNA tags. Since the barcode DNA was obtained 
from the kit, the same kit was suitable for the subsequent NASBA assay.19,129 
 Results and discussion: 
The data of on-chip IMRAMP tests were recorded by a microplate reader and showed in 
Figure 13, see also Article I. The concept of ‘threshold time’ was defined artificially for 
the comparison of amplification signals, according to the concept of the cycle threshold 
(Ct) value used in RT-PCR (Real-time polymerase chain reaction) assays. The Ct 
represents the time required for the fluorescent signal to exceed background noise level. 
Higher target concentrations will result in shorter threshold times in the amplification 
assay.19 
The relationship between sample concentration and threshold time is a decreasing 
function. The LOD of IMRAMP assay is about 105 CFU/mL, similar to other antibody-
based methods. This result indicated that the LOD of the immuno-NASBA may be 
predominantly determined by the antibody affinity rather than by the follow-up 
amplification step. However, the amplification of biological signals can reduce the 
requirement of detection instrumentation, thus reducing the system cost. An immuno-
NASBA LOC allows for the detection of up to six different targets. ACTH, E. coli and 
rotavirus in multiplex samples were also tested, which results indicated that the 
interference within multiplex IMRAMP assays might occur, see also Article I. 
Contamination of RNase is a significant problem during the IMRAMP assay for 
protection of RNA molecules in the test. The RNase present in the sample cannot be 
avoided, and likely enters the system upon sample loading. To reduce the potential for 
RNase contamination, the chambers are frequently rinsed by using buffers. DNA rather 
than RNA was chosen here as the barcode tag for detector antibodies because of its 
resistance to RNase. However, high concentration of barcode DNAs in the reagent might 
become other contaminants, leading to false-positive results. 
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Figure 13. Quantitative detection assays on immuno-NASBA chips.19 Reproduced 
from Ref. 19 with permission from the Royal Society of Chemistry. (a) The IMRAMP 
assays produces standard amplification curves at ACTH concentrations between 1×10-9 
mol.L-1 and 1×10-12 mol.L-1. (b) The plot of the threshold times for the ACTH standard 
solutions in the IMRAMP assays. The ‘sample’ in inset A or inset B refers to an ACTH 
solution of 5 × 10-13 mol.L-1. (c) The threshold time of E.coli sample (at 1.2×106 cells/mL) 
is between those of the 5.5×106 cells/mL and 4.6×105 cells/mL standards. (d) The 
threshold times for diluted rotavirus solutions were similar as inset C. The ‘sample’ in 
inset D refers to the rotavirus solution of 1×10-2 µg/ml.19 
 Summary of the study: 
o The divided LOC system is easy to implement, especially given that the 
low-cost LOC is compatible with ubiquitous bench-top instrumentation. 
o There are four main limitations of low-cost LOCs: the limited machining 
precision, the limited accuracy of fluid operations, limited measurement 
equipment, and the intrinsic characteristics of on-chip biochemical tests. 
Since the cost remains a limiting factor, the biochemical tests carried out 
on LOCs are likely general opportunities for further improvement of LOCs. 
o This LOC employed a DSM similar to traditional ELISA testing to meet 
the needs of multi-channel detection of biological targets. It remains an 
obstacle: only a semi-quantitative test could be achieved in the study. 
o A series of higher-density LOC devices could be derived from this LOC, 
which is designed to be compatible with standard 96-well microtiter 
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plates. The 384 or 1536 well microtiter plates can also be read in the 
common microplate readers. If the chamber density of the LOC increases 
accordingly, the divided LOC framework will remain functional. 
2.1.2 Multifunctional sample preparation kit and on-chip quantitative 
NASBA tests for microbial detection. 
 Background 
See also Chapter 1.2.1. 
 Objectives: (Article II) 
To develop a set of convenient low-cost tools for the quantitative investigation of 
microorganisms present in aquatic environments. 
 Main relevant projects: 
o FoU-forprosjekt i VRI Fund (Intelligent vannprøvetakeutstyr, Project No.: 
38042) 
o Oslofjord Fund (Real-time quantitative IMRAMP microfluidic system, 
Project No.: 202444); 
o The Norwegian Micro-Nanofabrication Facility, Norfab (197411/V30) 
 Challenges: 
o Is it possible to readjust the microplate reader-compatible immuno-
NASBA LOC for the investigation of environmental microorganisms? 
o How can a seamless connection between field sampling and in-house 
detection be achieved? 
o How can the parallel quantitative capability of multiplex molecular 
detection be improved? 
o How can the method of quantification for NASBA tests be improved? 
 Design of the LOC system and its DSM: 
The LOC in this work was named the ‘Q-NASBA chip’, and the DSM was derived from 
the existing PFU method to evaluate environmental pollution in fresh water. In general, 
the PFU method is based on the statistics of the microorganisms living in an aquatic 
environment, as described in the Chapter 1.2.1. The implementation of the traditional 
PFU method is manual and time-consuming, severely limited in two stages: the sampling 
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process and the detection process. If the laboratory is located far from the sampling point, 
the composition of samples may change during transport. As for the detection process, 
operators with sufficient knowledge of microbiological taxonomy have to manually 
identify and count different types of living microorganisms under a microscope. In this 
work, a sampling kit was developed for the collection of microbes, including a specific 
sampling tool with optional built-in membrane filters, and a coordinated sample 
preparation cassette for the optimisation of the sampling process (Figure 14, see also 
Article II).15 
 
Figure 14. Components of the multifunctional sample preparation kit.15 Reprinted 
with permission from Ref. 15, Copyright 2012, American Chemical Society. (see also 
Article II) 
This low-cost sampling kit is seamlessly connected with the subsequent sample 
preparation. The microbes collected in the filter set can be immediately stored in a specific 
preservation buffer to protect DNA/RNA molecules, which provides enough time to 
transport samples to a core laboratory.15 We altered the reported six-channel immuno-
NASBA LOC (Figure 10) to obtain a 24-channel chip for Q-NASBA assays (Figure 15).15 
The on-chip Q-NASBA assay can be regarded as a sandwich hybridisation-based NASBA 
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assay (Figure 16),15,130 similar to a multiplex NASBA assay. Different RNA templates are 
enriched in different chambers to avoid any interference between samples in the system. 
As a result, different molecular beacons (MBs) in the multiplex NASBA system can share 
the same fluorescence group, which reduces the requirement for detectors.15 Furthermore, 
a novel analytical algorithmic method for better quantification of on-chip NASBA was 
also developed. 
 
Figure 15. Architecture of the Q-NASBA chip.15 Adapted with permission from Ref. 
15, Copyright 2012, American Chemical Society. The six-channel LOC with micro-
channels and chambers was made using both polymer and silicon. A gold film was 
deposited on the surface of each chamber. A common microplate reader can be used to 
read the LOC as a standard 384-well microtiter plate.15 (See also Article II) 
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Figure 16. Mechanism of amplification for the on-chip Q-NASBA assay.15 Adapted 
with permission from Ref. 15, Copyright 2012, American Chemical Society. ‘Capture 
probes’ are specific single-stranded DNA molecules that can anchor onto the gold surface 
layer to capture corresponding RNA templates for NASBA assays. The 5’-end of each 
probe was furnished with a 15-mer thymine linker and modified by a mercapto group that 
can chemically couple with gold atoms.15,131,132 The 3’-end of each probe contained the 
identical sequence as the ‘reverse primers’ in the NASBA assays.15 
 Experiments: 
The sampling and transport processes are used to condense microorganisms from an up 
to 2L water sample onto the membrane filter in a specific filter set. The sample 
preparation cassette was designed to lyse the microbial cells retained on the filter set and 
to extract their DNA/RNA contents to minimize contamination during the procedure 
(Figure 14). The Q-NASBA chips and relevant components were prepared using both 
polymers (PDMS and PMMA) and silicon. The inner surfaces of reaction chambers were 
manually treated using pipettes, as previously described.15,131 In this work, 
Saccharomyces cerevisiae, Staphylococcus aureus and E. coli were selected as the testing 
targets to demonstrate the system function. (See also Article II) 
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Three groups of probes and primers were used in Q-NASBA assays, including ‘pan-
fungal probe and primers’ for S. cerevisiae, ‘pan-gram-positive probe and primers’ for S. 
aureus, and ‘pan-gram-negative probe and primers’ for E. coli. Zhao et al. reported the 
following primers and probes in 2009:15,133 
1. Pan-fungal probe and primers: (Target: 28S rRNA)133 
Forward primer: 5’ CGGCTCTTCCTATCATACCG 3’ 
Reverse primer: 5’ AATTCTAATACGACTCACTATAGGGCTAAACCC 
                               AGCTCACGTTCC 3’ 
Molecular beacon: 5’FAM-CGCGATATTCGGTAAGCGTTGGATTGAT 
                                   CGCG –Dabcyl 3’ 
Capture probe: 5’SH-(T)15 –Reverse primer-3’ 
2. Pan-gram-positive probe and primers: (Target: 16S rRNA)133 
Forward primer: 5’ TACGGGAGGCAGCAGT 3’ 
Reverse primer: 5’ AATTCTAATACGACTCACTATAGGGGCTGCTGG 
                                           CACGTAGTTAGCCGTGGCTTTC 3’ 
Molecular beacon: 5’FAM-CGAGCTAGCAACGCCGCGTGAGTGAA 
                                                GCTCG–Dabcyl 3’ 
Capture probe: 5’SH-(T)15 –Reverse primer-3’ 
3. Pan-gram-negative probe and primers: (Target: 16S rRNA)133 
Forward primer: 5’ CCTGATGCAGCCATGCCGCGTG 3’ 
Reverse primer: 5’ AATTCTAATACGACTCACTATAGGGCACGGAGTTA 
                                          GCCGGTGCTT 3’ 
Molecular beacon: 5’FAM-CGAGCTTGAAGAAGGCCTTCGGGTTGTA 
                                               AAGAGCTCG –Dabcyl 3’ 
Capture probe: 5’SH-(T)15–Reverse primer-3’ 
The chambers in the LOC were coated with different probes with different detection 
specificies.15 Then, the LOC was operated through an external pump and valve system, 
see also Article II. 
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 Results and discussion: 
To verify the accuracy of Q-NASBA assays performed using a microplate reader, the 
initial tests were conducted manually on PCR plates. In the present study, the total RNA 
of S. cerevisiae was purified and used as standard samples for Q-NASBA tests. The results 
are presented in Figure 17, inset A. At total RNA concentrations between 1 ng·L-1 and 1 
µg·L-1, the Q-NASBA assays exhibit standard amplification curves. 
The threshold time (Ct) is redefined artificially as the time required for the fluorescent 
signal to exceed the background noise. However, as the noise levels of NASBA assays 
can vary, the artificial threshold for Ct values lacks a solid standard. To address this 
concern, a moving threshold was defined as 105% of the average fluorescence value of 5 
min before every measurement. The amplification time when the measured value 
exceeded its moving average threshold for the first time was defined as Ct. Subtracting 
each measured value from its moving threshold yields the value of difference value, as 
demonstrated in Figure 17, Inset B. 
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However, the measured values may occasionally exceed their moving thresholds within 
the first 20 min because of the initial temperature fluctuations inside the microplate reader， 
but significant Ct values are always found to occur after 25 min; therefore, the first 20 
min can be ignored if abnormal data are also observed for the negative control. This 
method yields a good linear curve between Ct and the logarithm of template concentration 
(Figure 17, Inset C). S. cerevisiae was used to demonstrate the function of Q-NASBA 
chips, whereas S. aureus and E. coli were employed in the subsequent recovery tests on 
Q-NASBA chips. The testing results of S. cerevisiae are presented in Figure 17, insets D, 
E and F. The preliminary tests confirmed that the on-chip Q-NASBA is a sensitive method 
for the quantification of S. cerevisiae in water. The LOD of the Q-NASBA platform for 
microbes in water samples is above 102 cells·L-1. Known amounts of S. cerevisiae, S. 
aureus, and E. coli were added to the natural water samples acquired from a reservoir, 
and analysed in the LOC devices. Excellent recoveries were obtained for microbe cells in 
the samples ranging from 90% to 120%, see also Article II. 
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The hybridisation of target nucleic acids to immobilized probes is a critical challenge to 
on-chip Q-NASBA tests. It is subject to probe length and density effects, as well as to 
surface charge and chemistry.15,130,134,135 The tolerable LOD of this LOC may also be also 
attributed to the low efficiency of RNA extraction and hybridisation. One improving 
method could involve amplifying the templates by multiplex PCR/NASBA and extending 
the hybridisation time to enhance output signals.15,136-138  
 
Figure 17. Typical results of Q- NASBA assays.15 Adapted with permission from Ref. 
15, Copyright 2012, American Chemical Society. Insets A, B and C present the testing 
results from PCR plates, whereas insets D, E and F present the results obtained with the 
Q-NASBA chip. The arrows in Insets B and E show the locations of each ‘Ct’ point, where 
the abscissa presents the relative Ct values. (See also Article II)15 
 Summary of the study: 
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o The results of this study indicated that Q-NASBA assays can be performed 
successfully in a common microplate reader. Moreover, the method of 
quantification for NASBA tests was also improved. In addition, we found 
that Ct values always occur before 1 h; therefore, the total reaction time of 
Q-NASBA assays can be shortened to 70 min. 
o This system design reflects a simple principle that sample preparation is 
critical for error propagation throughout the whole procedure. Without 
accurate sample preparation, any result in the detection cannot be 
completely trusted.15 The seamless connection between the sampling 
module and the detection module helps operators decrease the possibility 
of contamination and sample loss, the most destructive factors for such 
quantitative tests. 
o The multifunctional LOC system successfully simplified and standardized 
the complicated processes of multiple Q-NASBA assays, but the system 
design still contains some redundancies. More in-depth studies are 
required before this LOC is utilized in practical applications. 
o This series of microplate-compatible LOCs could likely be further 
developed to produce a low-cost microarray. 
2.1.3 Rapid identification and susceptibility testing of uropathogenic 
microbes via an immunosorbent ATP-bioluminescence assay on a 
microfluidic simulator for antibiotic therapy. 
 Background 
UTIs are among the most common bacterial infections and mainly caused by 
bacteria.70,121,139,140 The most common UTI-causing organism is E. coli, with 80%–85% 
of cases originating from these bacteria. Staphylococcus saprophyticus are responsible 
for 5%–10% of UTI cases, and UTIs also can be caused by viral or fungal infections.121 
Other groups of bacteria can also cause UTIs.121 UTIs are often treated with 
antibiotics.70,141 The standard diagnosis of UTIs in hospitals relies on culture-based 
identification and antimicrobial susceptibility testing (AST), which have typical delays 
of a couple of days.70,142  
In the absence of a definitive microbiological diagnosis, doctors frequently initiate an 
imprecise empirical broad-spectrum antibiotic treatment to meet the urgent needs of 
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patients.139 A growing problem of worldwide concern is the increasing resistance of 
pathogens to conventional antibiotics10.143 Although the diagnostic technology for UTIs 
has advanced, the existing methods or tools remain too slow to achieve timely and 
judicious antibiotic treatment in practice.70 
 Objectives: (Article III) 
To achieve rapid diagnosis of UTI pathogens using high-throughput LOC technology and 
provide a low-cost efficient medical simulation platform for AST, enabling the selection 
of appropriate antibiotics. 
 Main relevant projects: 
o Oslofjord Fund (Touchsensor, Project No.: 234972); 
o The Norwegian Micro-Nanofabrication Facility, Norfab (197411/V30) 
 Challenges: 
o Is it possible to readjust the previously developed disposable LOCs that 
are compatible with microplate readers for this new application of urine 
testing? 
o How can a low-cost LOC be developed that integrates the multiple 
functions of immunoassay, cell culture, rapid quantification of living cells 
and AST? 
o How can the multiple tests on the disposable LOC be accelerated? 
o How can the qualitative method of the ATP bioluminescence assay be 
converted to a semi-quantitative on-chip method with some specificity? 
 Design of the LOC system and its DSM: 
This work reports the design of a cell-based LOC system to accomplish the integrated 
functions of rapid microbe identification and AST, named ‘microfluidic simulator’ or 
‘medical simulator’. Compared with other emerging methods, the culture-based method 
remains robust and reliable, with the results that the culture-based method is selected for 
the DSM of this LOC. Target microbes in the urine sample will be captured by specific 
antibodies in the LOC device and encapsulated by the hydrogel in situ. Given enough 
growth medium, the immobilized microbes can grow there prior to quantification and 
follow-up testing. Accordingly, the immunosorbent ATP-bioluminescence assay (IATP-
BLA) was selected as a fundamental measurement method for the LOC to identify and 
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evaluate the properties of uropathogenic bacteria. The ATP bioluminescence assay (ATP-
BLA) has been described in Chapter 1.2.1.1. The magnitude of the ATP bioluminescence 
signal is proportional to the amount of living microbes. Because the specificity of 
immunoassay and the high sensitivity of the ATP-BLA can be perfectly integrated into 
the 384-chamber LOC, this device can simultaneously perform rapid microbial tests on 
13 types of microbe strains prior to AST for eight selected antibiotics. The entire 
processes of immunoassay, cell culture, ATP-BLA and AST were smoothly integrated in 
the LOC. Compared with traditional urine culture testing, the LOC accelerates the time 
to result from a few days down to hours.(Figure 18)70 (See also Article III) 
 
Figure 18. The typical process of the microfluidic simulator in a UTI case.70 
Reprinted with permission from Ref. 70, Copyright 2015, American Chemical Society. 
(See also Article III) 
The LOC is designed with 384 vertical reaction chambers with dimensions corresponding 
to those of a standard 384-well microtiter plate as in Chapter 2.1.1 and 2.1.2, as shown in 
Figure 19. This design ensures that the signals from the microfluidic LOCs can be directly 
read using a common microplate reader. The schematic diagram of the on-chip IATP-
BLA is shown in Figure 20. Due to the hydrophilicity of the glass fibres, the aqueous 
phase penetrates laterally towards the nearby reaction chambers with small particles such 
as bacteria, but large clots or mucilage are obstructed due to the limited size (<2.7 µm) of 
the apertures inside the fibreglass membrane. The antibodies immobilized on the glass 
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fibres capture target microbes. The captured microbes are encapsulated in a thin film of 
calcium alginate gel by the following gelation reaction:144 
  NaHACaNaAHACa 2
2 lg)(lglg  
 
Figure 19. The architecture of the microfluidic LOC.70 Reprinted with permission 
from Ref. 70, Copyright 2015, American Chemical Society. (a) Downward view of the 
chip layout. Three layer components: the Sample Layer (SL), the Membrane Layer (ML) 
and the Culture Layer (CL). (b) Upward view of the chip layout. 11 groups of culture 
medium veins (CMVs) are engraved on the lower face of the CL. (c) The inlets and outlets 
of the device. (d) Vertical reaction chambers in the cross-sectional view. (e) Groups of 
detection channels. Each group of CMVs is an independent detection channel. Every 
CMV covers 16 reaction chambers, including 13 IgY-coated detection units for 
uropathogens, an ovalbumin control, a normal mouse serum control, and a blank control. 
Groups 1-2 have three replicates, respectively; Groups 3-11 have only two replicates.70 
(See also Article III) 
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Figure 20. The typical protocol of the IATP-BLA test in the microfluidic LOC.70 
Reprinted with permission from Ref. 70, Copyright 2015, American Chemical Society. 
Specific IgY antibodies were immobilized on the fibreglass membrane during fabrication. 
The standard operating procedure is: (1) the urine sample is loaded into the sample veins, 
and the specific microbes are captured by IgY antibodies; (2) unbound microbes are 
removed; (3) the captured cells are encapsulated in situ by calcium alginate gel; (4) the 
sodium alginate solution is washed away; and (5) paraffin oil is injected to isolate each 
reaction chamber. Subsequently, different channels will be processed differently. (6.0) 
The captured microbes can be reproduced before ATP-BLA; (6.2) the captured microbes 
can be inhibited by a series of antibiotic regimens before ATP-BLA; or (6.1) the captured 
microbes can be inhibited by a single antibiotic in AST. Either way, (7) the cells will 
finally be quantified by ATP-BLA using a microplate reader.70 (See also Article III) 
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 Experiments: 
The microfluidic device is constructed of two white polystyrene (PS) sheets that were 
processed by laser ablation, between which a piece of Waterman™ grade GF-D fibreglass 
membrane filter was tightly clipped. Various reagents can be added to each reaction 
chamber through 24 CMVs. Each group of CMVs shares the same inlet and outlet pair. 
In the LOC, 16 vertical reaction chambers are designed for each CMV. The fibreglass 
membrane inside of the 13 chambers is immobilized with 13 types of specific chicken 
egg yolk antibodies (IgY) against their respective corresponding uropathogenic microbes, 
including E. coli, Staphylococcus saprophyticus, Staphylococcus epidermidis, 
Staphylococcus aureus, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas 
aeruginosa, Enterobacter cloacae, Enterococcus faecium, Enterococcus faecalis, 
Streptococcus viridans, Streptococcus pyogenes and Candida albicans. The other three 
chambers in each CMV are for controls. (See also Article III) 
Surface treatment of the fibreglass membrane was prepared in the same manner as poly-
L-lysine-coated glass slides.145 The protein solutions were transferred by pipetting into 
the corresponding chambers from the top of the air veins, with approximately 0.6 µL of 
solution added per chamber. The resulting components were incubated for 1 hour at 298K 
and then freeze-dried and sealed with transparent sealing tapes.70 The LOCs were 
operated by a manual valve and pump system.70 The 13 types of microbe clones were 
provided by cooperating hospitals and were the same strains as those used as the antigens 
for immunization. Flinn Scientific© artificial urine was spiked with the 13 types of 
microbes, and a series of microbe-containing artificial urine samples were made and 
tested. The relative luminescence unit (R.L.U.) data were collected by a microplate reader 
and analyzed by using Microsoft Excel® and OriginPro®. To validate the on-chip AST, an 
artificial urine sample containing 1000 cells/ml was loaded into a microfluidic LOC and 
tested by ampicillin, carbenicillin and erythromycin. The R.L.U. data of ATP-BLA were 
then collected.70 (See also Article III) 
 Results and discussion: 
All operations from sample processing to ATP-BLA are smoothly integrated to reduce the 
turnaround time. For example, the sample processing employs lateral-flow across the 
fibreglass membrane, which not only allows for the immune capture of target microbes 
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but also acts to filter irrelevant particles from the sample. The tests showed that 
microfluidic LOCs can specifically recognize the microbes in the artificial urine samples 
containing multiple microbes (Figure 21).70 A significant difference can be observed 
between microbes and ovalbumin-coated negative controls at concentrations above 1000 
cells/ml, but it is also indicated that the on-chip ATP-BLA results cannot directly reflect 
the number of living microorganisms regardless of species. The method can be used to 
evaluate the numbers of microbes within the same species. We were not able to 
distinguish the difference at target microbe concentrations below 100 cells/ml.70 
Interestingly, the R.L.U. value of E. coli in a sample of 1×106 cells/ml generally appeared 
to be saturated, shown in Figure 21, inset B. This implies that the general measurement 
range of immediate IATP-BLA ranges from 1×103 cells/ml to 1×105 cells/ml, which is 
within the clinical cutoff of urine culture tests.146 Moreover, cell cultivation prior to the 
2nd round of ATP-BLA can improve the LOD, because in general, pathogenic microbes 
can grow exponentially in the growth medium. For example, if one E.coli cell is initially 
captured, hundreds of E.coli cells will proliferate in situ after 3 h of cultivation, which 
can be easily detected by the 2nd round of the ATP-BLA test.70 
The signals of the blank controls are lower than those of negative ovalbumin controls 
(Figure 21, inset A), implying that the coated protein on the fibreglass potentially increase 
the nonspecific absorbance of microbes compared with that of raw fibreglass. 
Furthermore, the normal mouse serum controls were more similar to the detection items 
than to the negative controls (Figure 21, insets A and C). The specific absorbance of 
normal mouse serum should be related to Protein A and Protein G, which are derived from 
S. aureus and Streptococcus species. Both proteins have binding sites for the Fc portion 
of mammalian IgG, including the IgG in the mouse serum. For this reason, IgY antibodies 
from chicken were finally selected to replace the common IgG antibodies of 
mammalian.70 
Given the proper cell culture conditions, hydrogel encapsulation is not an essential 
requirement for the growth of cells, but the hydrogel can restrict the movement of 
microbes. Aeration is another important factor for the on-chip AST. Parameter 
optimisation enabled good AST results using the LOC (Figure 21, inset D). The rate-
limiting step of AST is the bacterial growth. According to our experience, cultivation for 
three hours could increase the limit of detection by at least one order of magnitude. 
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However, no firm conclusions can be drawn regarding this cultivation as different strains 
have different growth rates.(See also Article III)70 
 
Figure 21. The rapid identification of 13 microbes and AST using the microfluidic 
LOCs.70 Adapted with permission from Ref.70, Copyright 2015, American Chemical 
Society. (a) Serially diluted samples of artificial urine containing multiple microbes were 
tested. (b) The concentrations of E. coli in the serially diluted samples of artificial urine 
were measured, whereas the R.L.U. data of the negative controls are also shown as the 
background. A power regression analysis on R.L.U. values and relative cell 
concentrations (from 100 cells/ml to 1×105 cells/ml) produced a good fit curve (n=6, 
R2=0.99482). (c) Thirteen standard samples with 1000 cells/ml of different single species 
were measured. (d) A typical on-chip AST was demonstrated. In the test, a sample of 
artificial urine containing 1×103 cells/ml was treated with 20 mg/L ampicillin, 500 mg/L 
carbenicillin and 50 mg/L erythromycin (n=4).70 (See also Article III) 
 Summary of the study: 
o This microfluidic simulator is a patient-specific modelling device to 
enable the personalized treatment of UTIs. The LOC operates on a similar 
principle as conventional urine culture and AST in petri dishes, but 
accelerates the testing. Although this approach provides a promising new 
option for the diagnosis and treatment of UTIs, large-scale clinical 
validation is required. 
o The integration of the specificity of immunoassays and the sensitivity of 
the ATP-bioluminescence assay enables this sensitive cytometric method 
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for the detection of specific living cells. Due to the high efficiency of on-
chip IATP-BLA tests, the LOC device supports the rapid identification of 
the most common causative agents of UTIs and enables subsequent AST 
testing within 3-6 hours. 
o Cell-based LOC technology could use cells, pathogen-containing tissues 
or tumour cells from individual patients to construct personal rapid 
simulation models for personalized clinical treatment, thereby reducing 
the risks of therapy. With increasing demand for personalized treatments, 
more and more medical simulators will be developed, especially for 
chronic incurable diseases such as chronic hepatitis, diabetes, cancer, and 
rheumatism.70,147 
o A low-cost LOC system is a feasible way to implement such complex 
detection. Due to its compatibility with a microplate reader, the series of 
LOCs provides a good example of functional integration on a low-cost 
chip. The divided LOC system is suitable for the implementation of 
complex automation associated with high-throughput detection, 
particularly for tests of living cells. 
2.2 LOC devices containing integrative biological systems with 
unconventional DSMs: a microfluidic device for 
continuous sensing of systemic acute toxins in drinking 
water 
Compared with the LOCs based on conventional DSMs, the designs of these 
unconventional LOC systems allow for better performance. However, unconventional 
DSMs often require more evaluation; accordingly, large-scale long-term experiments are 
required for the validation of their designed functions. 
 Background 
See also Chapter 1.2.1.2. 
 Objectives: (Article IV) 
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To develop a continuous, cost-efficient LOC system to evaluate the threat of acutely toxic 
chemicals. 
 Main relevant projects: 
o Norwegian long term support from NorFab (living-cell-based LOC 
project); 
o Oslofjord Fund (Et cellebasert digitalt mikrofluidisk system, Project No.: 
220635); 
o The Norwegian Micro-Nanofabrication Facility, Norfab (197411/V30); 
 Challenges: 
o Is it possible to translate the traditional discrete-time protocol of the 
bioluminescence toxicity test using V. fischeri into a continuous test 
carried out on a chip? 
o How can a continuously functioning monitor be implemented at low cost? 
o How can the continuous steps of sample loading, mixing and detection be 
carried out in the LOC? 
 Design of the LOC system and its DSM: 
The principle of the luminescent bacteria test relies on the inhibition of light emission by 
V. fischeri in response to the effects of toxic chemicals.21 Generally, the inhibition test in 
ISO11384 is accomplished by tests with specified volumes of a suspension of luminescent 
bacteria in a cuvette. The test criterion is the decrease in luminescence, measured after 15 
min and again after 30 min. Parallel measurements of changes in the luminescence 
intensity of standard control samples can be used to determine the inhibition rate.21 Here, 
the unconventional DSM of the V. fischeri cell-based LOC was developed according to 
traditional periodic tests, named a ‘living-cell chip’ (Figure 22). 
In the LOC, water samples and a suspension of luminescent bacteria will be continuously 
added to the micro-mixers at a fixed flow rate. The mixture has to flow through a long 
spiral-shaped micro-channel before reaching the observation chamber, with the result that 
20-30 min has passed from the time of mixing to the time of optical measurement. 
Theoretically, the basic principle of the on-chip test is similar to that of the periodic test. 
In addition, when the flow rates and other conditions of the LOC system are fixed, the 
flow will result in a steady state luminescent intensity in the observation chamber. The 
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inhibition rate based on the light emission can be evaluated by comparison with a parallel 
control system. 
 
Figure 22. Construction of the cell-based LOC device.21 The map of the chip domains 
is shown at the bottom. The sample, buffer solution and cell suspension are mixed to form 
droplets within the airflow (see also Article IV).21 
The complete LOC system is composed of five major components, including a sampling 
module, peripheral actuating devices (i.e., valves and pumps, etc.), a cell-culture module 
for V. fischeri, a cell-based LOC device and a photomultiplier-tube-(PMT)-based photo-
sensing module. The non-clogging micro-concentrator in the previous report was 
employed as the sampling module for drinking water.148 Copper (Cu2+), zinc (Zn2+), 
potassium dichromate and 3, 5-dichlorophenol were selected as typical toxins to validate 
the LOC system.21 
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 Experiments: 
The toxicity of the water sample was evaluated by measuring the intensity of emitted light 
measured by the PMT-based detection module, as shown in Figure 23.21 The PMT was 
used as a sensitive detection module with low power consumption and low noise, and 
these signals were imported into a computer prior to analysis using Microsoft Excel® and 
OriginPro® software.21 (See also Article IV) 
 
Figure 23. Schematic of the detection system.21 The droplets continuously flow 
through the observation chamber. After a short period, the contents of the observation 
chamber are totally replaced. Then, the detection system performs periodic measurements 
of the observation chamber.21 (See also Article IV) 
The CuSO4 and ZnSO4 solutions were serially diluted in deionized water as model toxin 
samples, which concentrations ranged from safe levels below the guidelines in potable 
water to poisonous levels far above the legal limit for drinking water quality.149,150 The 
solutions of 50 mg/L potassium dichromate and 4 mg/L 3, 5-dichlorophenol were 
prepared in deionized water and used as the artificial contaminated water samples. 
Deionized water and 2% NaCl were used as blank solutions. A solution of 60 mg/L 
cetylpyridinium chloride (Weifa®, Oslo, Norway) was employed as a positive control, 
since cetylpyridinium chloride (CPC) is a broad-spectrum antibacterial agent. V. fischeri 
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came from the BO1243-500 BioToX™ Kit (Aboatox Oy®, Masku, Finland). See also 
Article IV. 
The volumetric flow rates for the test samples, buffer solutions, bacterial suspensions and 
air flows were at a constant ratio of 1:1:2:4. The ‘droplet flow rate’ is defined as the total 
volumetric flow rate of the three liquid solutions. The ‘response time’ of the sensing 
device is defined as the period from the moment the first droplet is formed to the moment 
that the observation chamber is filled by the droplets. After the response time and 
sampling interval of the LOC system were studied in initial tests using serial dilutions of 
CuSO4, the 20 µL observation chamber was selected as the default chamber volume. 
Moreover, the droplet flow rate was fixed at 4×10-11 m3/s for all other toxicity tests.21 
Because the system continuously monitors the water samples, the observation chamber is 
measured over a specific period, which is defined as the ‘sampling interval’.21 This period 
is set to coincide with the period over which the droplets in the observation chamber are 
expelled and replaced by fresh ones. (See also Article IV) 
 Results and discussion: 
Six Cu2+ solutions were tested in the cell-based sensing device at several droplet flow 
rates (Figure 24, inset A).21 The LOC responses to approximately 0.05 mg/L Cu2+ or Zn2+ 
solutions are similar to the responses for deionized water, which is in line with the WHO 
standards for drinking water quality (< 2 mg/L).150 The results for the group with 0.05 
mg/L Cu2+ were very similar to the results for the deionized water group. However, the 
solutions of 0.5 mg/L Cu2+ and 2.5 mg/L Cu2+ exhibited some toxicological effects on the 
V. fischeri cells (Figure 24, inset A). The results for the positive control group (60 mg/L 
CPC) were in line with expectations (i.e., their bioluminescent signals were close to zero). 
21 The Zn2+ solutions were also measured using the standard settings and analysed (Figure 
24, inset B). A non-linear relationship between the Zn2+ concentration and the R.L.U. was 
observed, but this LOC system is useful as a broad-spectrum early warning tool rather 
than as a quantitative system. 21 The artificial samples of tap water were also tested in the 
cell-based LOC system, and the results indicated that the cell-based LOC can easily 
distinguished toxic contamination from safe drinking water(Figure 24, inset E).21 
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Figure 24. Toxicity test results for the V. fischeri cell-based LOC system.21 (a) The six 
sample solutions (2% NaCl, deionized water, 0.05 mg/L Cu2+ solution, 0.5 mg/L Cu2+ 
solution, 2.5 mg/L Cu2+ solution and 60 mg/L CPC) were tested at different droplet flow 
rates. (b) Nonlinear regression between [Zn2+] and the RLU data. (c) Response time and 
sampling interval of the sensing device. (d) Observation chambers with volumes of 5 µL, 
10 µL and 20 µL were tested. (e) The drinking water sample and five artificial solutions 
were tested, including 2% NaCl, deionized water, a drinking water sample, 50 mg/L 
potassium dichromate, 4 mg/L 3, 5-dichlorophenol and 60 mg/L CPC. (f) Parallel tests 
for the six spiral microchannels.21 (See also Article IV) 
When the droplet flow rate decreased below 2×10-11 m3/s, the response time increased to 
more than 30 min (Figure 24, inset C). The standard droplet flow rate was selected as 
4×10-11 m3/s to limit the response time to within 30 min. When different observation 
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chambers and spiral micro-channels were tested in parallel experiments, the results 
showed that using a smaller observation chamber led to larger relative errors (Figure 24, 
inset D), whereas switching among different spiral micro-channels had no significant 
impact on the results (Figure 24, inset F). The 20 µL observation chamber was preferred.21 
In this study, the converted EC50 value for copper (II) was approximately 0.5 mg/L, and 
the equivalent exposure time was almost 30 min. The traditional toxicity assessment using 
V. fischeri cells as biosensors is based on the inhibition of luminescence. The toxicity is 
usually captured as the EC50, which is the effective concentration of the tested chemical 
at which 50% of the luminescence is inhibited.151 The reported EC50 values for copper 
(II) exposure of V. fischeri range from 0.15-0.58 mg/L at an exposure time of 30 min.152. 
Here, the continuous tests in the LOC device were in line with the traditional periodic 
tests, but the standard reference values for the on-chip tests have to be modified due to 
the different physical environment of the LOC. 21 
 Summary of the study: 
o This living-cell chip is an appropriate early warning device to assess 
possible threats from toxic chemicals in water. Note that this cell-based 
LOC device was developed to assess the toxicity of chemicals in water 
rather than their concentrations. This study demonstrated that a traditional 
DSM could be modified for a specific LOC to realize a special purpose. 
The unconventional tailored DSM is generated for the contrived LOC. 
o The chip design of this LOC employs the infrastructure of digital 
microfluidics, which is a good solution for sample mixing, oxygen supply, 
and continuous detection. However, the digital microfluidic structure 
might be not optimal for the continuous culture of cell sensors. This LOC 
system has to employ an external bioreactor as the long-term source of 
living cell sensors, increasing the total cost. Furthermore, the tiny droplet 
volume leads to extraordinarily high requirements for the optical detection 
module. The LOC system should be further improved to address these 
limitations. 
o Currently, the living-cell chip has to work in a stable environment, making 
it difficult to deploy for field-testing. 
o Integration of the bioreactor and observation chamber into a single LOC 
would enhance the system performance and greatly reduce the system cost. 
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 Further study on a series of living-cell chips. 
Based on colorimetric reactions in a specific growth medium during the proliferation of 
living microbes, another tailored DSM was also investigated in the living-cell chip, the 
continuous monitoring of living bacteria in water.20 However, the response time was far 
from the desirable rapid response. Then, the digital microfluidics infrastructure was 
totally removed from the new version of the living-cell chip. Inspired by the natural coral 
reef arrangement, the 2nd generation living-cell chip was developed with a new design to 
enable early warning of the presence of toxic chemicals in drinking water. These results 
remain unpublished. 
The 2nd generation living-cell chip includes a coral-reef-like microfluidic bioreactor to 
accommodate bioluminescent cell sensors. A protected hydrostatic area is present behind 
each pillar unit, intended for the propagation of living organisms (Figure 25). The flow 
consisting of the water sample, nutritional substances and oxygen will continuously pass by 
pillar units as ocean currents pass through coral reefs. The semi-open structures take full 
advantage of the compactness of the microchip, resulting in the simple and efficient diffusion 
of oxygen, nutrients, and chemical analytes. The cell sensors can stay and multiply within 
the protected area; if the cell population is overcrowded, the excess cells will spread out of 
the protected area and be flushed away by the continuous flow of water. 
Given fixed conditions that meet the needs of the cells, the populations of living cell sensors 
in a LOC will reach a spontaneous steady state. Until toxic chemicals are introduced in the 
water samples, all the cell colonies in the LOC will be affected synchronously. Consequently, 
the bioluminescent signals will be stronger than the previous living-cell chip by several 
orders of magnitude, although the LOC still relies on the simple and low-cost 
microstructure. The bioreactor and observation chamber, separate in the 1st version of the 
chip, are perfectly integrated in the new version of the chip design. Moreover, the LOC 
naturally works continuously rather than periodically, and the water sample flows in a 
continuous stream around the resident cell colonies of the LOC. 
Compared with commercial online water quality monitoring equipment (see also Chapter 
1.2.1, Figure 7), the miniaturised LOC system is able to achieve long-term continuous 
monitoring with low consumption of reagents and energy. Moreover, due to the nature of 
living cell sensors, the cell-based LOC system has the ability to simultaneously detect 
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thousands of harmful substances. This 2nd generation living-cell chip has the potential to 
become an excellent early warning system for water safety. This device has entered the 
commercialisation process, and an international patent is currently being processed. 
 
Figure 25. The principle of the coral-reef-like microfluidic bioreactor present in the 
2nd generation of the living-cell chip.(unpublished) (a) A photo of a natural coral reef in 
the ocean current. (b) The bioluminescent cell sensors can form stable cell colonies in the 
reaction chamber with micro-pillar arrays. (c) The chemicals present in the water sample 
will continuously diffuse past the cell colonies. (d) Schematic sketch of bioluminescent 
cell colonies in the LOC. 
Although the DSMs of living-cell chips are still derived from known principles of existing 
biological protocols, their specific criteria were greatly modified to match the various 
LOC hardware designs. Compared with conventional cell-based toxicity tests, the series 
of LOCs are able to operate continuously over a long period to monitor a broad spectrum 
of harmful agents in drinking water. However, many doubts have been raised about the 
unconventional DSMs, and a long-term large-scale verification is required to demonstrate 
the function of living-cell chips. A follow-up research project has been initiated to address 
these questions. 
2.3 Database-oriented LOC devices to construct a prognostic 
DSM with computational modelling. 
Fascinatingly, this category of LOCs are developed prior to the birth of their DSMs. The 
LOC devices are employed to collect sufficient clinical data from relevant biomedical 
databases; based on these databases, predictive computational models can start to be 
established by using classification techniques; finally, various prognostic or diagnosis 
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DSMs can be created for these LOCs to evaluate health risks and identify dangerous 
health trends. Such LOCs will be both tools for building their own supporting databases 
and executive carriers of prognostic/diagnosis applications afterward. 
Blood testing is one of the main application field for prognostic LOCs due to the 
importance and frequency of these tests in medical diagnosis. The study of blood-related 
LOCs often extends beyond the scope of the microsystem due to its intrinsic 
interdisciplinary foundation. An acceptable LOC for blood testing will also involve 
knowledge from medical science, biology, biostatistics, materials science, ethics, and 
other fields. Any emerging biomedical LOC in this field requires a long period of research 
and validation. 
Many automatic instruments have been commercialized and implemented in hospitals for 
routine blood tests. For this reason, it is not necessary to develop new LOC tools for 
routine blood tests with the same DSM and function. However, blood samples contain an 
enormous amount of health-related information beyond that obtained through routine 
blood tests. This unused information could be used to detect diseases at an early stage, 
see also Chapters 1.1 and 1.2.2. The concept of a biomedical-database-dependent LOC 
system has been proposed for the acquisition of holistic data from blood tests. These 
emerging LOCs rely on the development of prognostic DSMs related to computational 
modelling in those biomedical databases. At present, research on these biomedical-
database-dependent LOC systems remains prospective. Undoubtedly, the construction of 
relevant biomedical databases and informatics research using data mining are arduous 
time-consuming tasks that must be carried out before these LOCs can achieve 
prognostic/diagnostic functions. 
The following work is a preliminary attempt in this direction. 
2.3.1 Design and fabrication of low-cost 1536-chamber microfluidic 
microarrays. 
 Objectives: (Article V, and a part of Article VI) 
To produce a low-cost LOC for the high-throughput quantification of signal molecules in 
blood, i.e., signal molecule profiling (SMP) 
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 Challenges: 
Is it possible to readjust the previous disposable LOCs that are compatible with microplate 
readers into a low-cost SMP chip? 
 Design of the LOC system and preliminary validation: 
A 1536-chamber microfluidic microarray chip, called the ‘SMP chip’ was designed 
(Figure 26).22 This chip can standardize the simultaneous detection of up to 384 types of 
signal molecules in a blood sample, with three parallel measurements of every target 
molecule. Similar to previous microplate-compatible chips, the SMP chip has the same 
dimensions as the 1536-well microtiter plate, thus making the SMP chip readable in a 
microplate reader. The low-cost material, PMMA was selected to construct the LOC. 
Moreover, PMMA is amenable to low-cost fabrication methods, i.e., carbon dioxide laser 
ablation in the R&D stage and injection moulding in the next stage of mass production. 
As there are no more than 400 hormones and cytokines present in the blood, the LOC 
contains sufficient measurement capacity. 
Here, the SMP chips operate by a chemiluminescent immunoassay (CLIA). CLIA is a 
sensitive detection method characterized by femtomolar sensitivity and high specificity. 
In addition, another type of SMP chip was also developed (Figure 27)18 operating 
according to the same quantitative method of IMRAMP (see also Chapter 1.2.1.1, Figure 
8 and Chapter 2.1.1). The SMP chip can be considered a low-throughput protein 
microarray with a 3D structure, which reaction interface is protected by a stereo structure. 
Current instruments available for handling ordinary microtiter plates could also be 
converted into instruments for the surface treatment of SMP chips.22 
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Figure 26. The layout of 1536-chamber microfluidic LOC.22 (See also Article V) 
The chip was modified by 16 types of different capture antibodies to measure relevant 
signal molecule targets, including thyroid-stimulating hormone (TSH), tumor necrosis 
factor-alpha (TNF-α), cortisol, follicle-stimulating hormone (FSH), luteinizing hormone 
(LH), human chorionic gonadotropin (HCG), erythropoietin (EPO), gonadotropin-
releasing hormone (GnRH), interferon-gamma (IFNγ), insulin-like growth factor 1 (IGF-
1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), 
interleukin (IL)-1 beta, IL-2, IL-6 and IL-8.22 (See also Article V and Article VI)  
 
Figure 27. The operating process of the SMP chip (Type B).18 (See also Article VI) 
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 Results and discussion: 
Normalisation of measurements between the two types of SMP chips provides data 
comparable to traditional ELISA methods. For example, the testing results of the 
IMRAMP-based SMP chips are presented in Figure 28.  
 
Figure 28. Comparison plots for results obtained using the traditional ELISA method 
vs. IMRAMP tests on the SMP chips.18 (a) IMRAMP results for detection of the TNF-α 
standard samples. (b) Plots comparing the test results for FSH. (c) Plots comparing the 
test results for LH. (d) Plots comparing the test results for TSH. (e) Plots comparing the 
test results for HCG. (f) Plots comparing the test results for cortisol.18 
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The LODs of both SMP chips are approximately 1×10−14 mol∙L−1, in the typical range of 
detection of common ELISA tests. Both tests can be regarded as extended blood 
examinations that aim to measure hundreds of the most important biomarkers in the 
blood, i.e., cytokines and hormones, which can fulfil the common requirements of 
medical diagnosis and the demands of data acquisition to construct a biomedical 
database.18  
2.3.2 Experimental approach to the construction of a human signal-
molecule-profiling database. 
 Objectives: (Article VI) 
To study the developing prognostic DSM of the SMP chip and design a low-cost roadmap 
for the construction of its corresponding database, the human signal-molecule-profiling 
database (HSMPD). 
 Challenges: 
o Is it feasible to develop a prognostic DSM for the SMP chip? 
o How can the HSMPD database for prognostic DSMs be practically 
constructed? 
o Is it possible for the SMP chip to be applied in hospitals in the absence of 
a mature database? 
o How can the medical system accept the SMP chip prior to the development 
of the first prognostic DSM? 
 System design and its developing prognostic DSM: 
The HSMPD will be an invaluable source of information for translational bioinformatics 
(TBI) research. It has been proposed to develop an HSMPD without creating an enormous 
scientific project. The success of the HSMPD project requires the cooperation of IT, 
instrumentation engineering, the traditional healthcare system and the TBI community 
(Figure 29).18 
The cost of data acquisition for developing a medical database is an impassable challenge, 
but it could be partially supported by the medical system as patients pay for their physical 
examinations. After all, SMP chips are more expensive than traditional diagnostic 
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reagents. The shortfall should be covered by public funding or else shifted to the database 
users in the TBI community. 
The data prioritisation scheme was designed based on the comments of potential users. 
HSMPD will adopt the framework of a relational database. Each record in HSMPD is 
divided into three interrelated sections with different information sources (Figure 30).18 The 
typical process of data acquisition in the HSMPD system is performed by hospitals, 
operating according to the procedures in Figure 31.18 
The SMP chips were provided as new tools for ordinary blood testing to clinical 
laboratories in the cooperating hospital. The test samples for the SMP chips were diluted 
sera, so a small volume of blood sample is sufficient for a single SMP chip. Namely, the 
remaining sample left from an ordinary blood test is usually sufficient to perform an 
additional SMP test.18 (See also Article VI.) 
 
Figure 29. Technology roadmap for the construction of the HSMPD.18 The HSMPD 
is a bridge to connect traditional health care systems with the TBI community. The 
HSMPD services to the TBI community can provide a stable stream of income to support 
the process of data acquisition for the HSMPD, resulting in a self-motivating 
mechanism.18 (See also Article VI) 
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Figure 30. Data structure of the HSMPD.18 Doctors, nurses and chip readers will input 
the clinical records into the HSMPD. The information in every record is categorized into 
two parts. The medical SMP data are open to all researchers and patients without 
unnecessary ethical review, whereas the private patient information is protected behind a 
firewall and can be accessed only by a trusted intermediary.18 (See also Article VI) 
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Figure 31. Typical process of data acquisition in HSMPD system.18 (See also Article 
VI) 
 Discussion and Outlook: 
This pilot study for an ambitious project concerning human disease diagnosis and 
prognostication tools enabled the development of a roadmap and specific LOC tools for 
data acquisition. The feasibility and methodology of data acquisition for the HSMPD was 
tested through the survey study and simulation tests. From the technical point of view, the 
LOC tools and relevant information technology plan have no serious problem. However, 
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due to the ethical risks and the work habits of doctors and nurses, it is difficult for a new 
tool or method to enter the existing medical system. It is even more difficult for the SMP 
chips that do not have a mature DSM or a biomedical database to enable their diagnostic 
and prognostication functions.18 Therefore, in the initial stage, the SMP chip has to be 
compatible with standard blood testing in the traditional diagnostic system until the 
relevant database and the first DSM come into being. Furthermore, the SMP chip has to 
be easy-to-use and low-cost to ensure participation by doctors and patients. Only wide 
adoption of such prognostic LOCs will enable the establishment of the relevant databases 
that will make these LOCs useful in medical practice. (See also Article VI) 
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3 Main conclusions and perspectives 
This doctoral thesis described an application-oriented strategy for the R&D of LOC 
systems, which was demonstrated in R & D activities in three aspects for detecting 
microorganisms, toxic chemicals and serological biomarkers. Various DSMs of these 
biomedical LOC devices were also analysed. The primary conclusions and perspectives 
of this thesis are summarized as follows: 
 A divided LOC system is easy to implement, especially given that low-cost LOCs 
are compatible with ubiquitous bench-top instrumentation. A series of LOCs has 
been developed to be compatible with standard 96/384/1536-well microtiter plates 
and is thus, compatible with microplate readers commonly utilized in standard 
biological laboratories. As the measurement stability of these microplate-
compatible LOCs has improved, microplate-compatible microarrays have been 
developed for multi-channel synchronous detection of biological targets, 
including microorganisms and serological biomarkers. Due to its compatibility 
with microplate readers, this series of LOCs provides a good example of 
functional integration on a low-cost chip. The divided LOC system is suitable for 
the implementation of complex automation associated with high-throughput 
detection, particularly for tests involving living cells. However, four main 
limitations still exist for low-cost LOCs: limited machining precision, limited 
accuracy in fluid operations, limited measurement equipment, and the intrinsic 
characteristics of on-chip biochemical tests. For cases in which costs are limited, 
it is feasible to enhance the performance of low-cost LOCs by improving on-chip 
biochemical tests. 
 These LOCs are capable of simplifying and standardizing the complicated 
processes involved in complex biological tests: 1) The IMRAMP assay is similar 
to traditional ELISA testing in a biomedical laboratory, and the signals in the test 
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can be amplified at least a million fold by follow-up NASBA assays. 2) Q-NASBA 
assays have also been demonstrated as suitable for microplate-compatible LOCs, 
in which the total reaction time can be shortened to 70 min. Both methods are 
characterized by a femtomolar sensitivity and high specificity. Moreover, a novel 
analytical algorithmic method has been generated for NASBA-based 
quantification tests, which improve the measurement ability of these LOCs. 3) 
The IATP-BLA test integrates the specificity of immunoassays and the sensitivity 
of ATP-BLA for living pathogens, which can be perfectly implemented on a 384-
chamber LOC, followed by a variety of in-situ operations, including urine culture, 
antimicrobial susceptibility testing and antibiotic therapy simulation. Due to the 
system design, this LOC supports rapid identification of the most common 
causative agents of UTIs and enables rapid AST testing within 6 hours. 
 For chemical contamination in water, most existing instruments for water quality 
detection are designed for a definite quantitative determination of specific 
chemicals, rather than a continuous early warning of broad-spectrum toxic 
chemicals. The LOC known as a ‘living-cell chip’ is an appropriate early warning 
device for assessing possible threats from toxic chemicals in water. This LOC 
device can continuously mix a water sample and Vibrio fischeri cell sensors into 
droplets, and this mixture is incubated for a long time before optical detection. 
The system represents a low-cost broad-spectrum monitor against potential toxins, 
such as heavy metal ions, phenol, etc. Moreover, the 2nd generation of this ‘living-
cell chip’ has been developed, which carries a coral-reef-like micro-bioreactor 
with the aim of improved performance.(unpublished) 
 A pilot study for an ambitious project concerning human disease diagnosis and 
prognostication tools has been carried out. The relevant LOC tools, called SMP 
chips, were designed, fabricated and tested. The candidate also studied the 
feasibility and process of data acquisition for a human signal-molecule-profiling 
database (HSMPD). Due to the work habits of doctors and nurses, it is difficult 
for SMP chips to be included in existing medical systems. In the initial stage, the 
SMP chip must be compatible with standard blood testing in the traditional 
diagnostic system until the relevant database and the first DSM are established. 
This doctoral study shows that an application-oriented strategy is feasible in the field of 
biomedical LOC research. More importance should be attached to the application 
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potential of research activities from the initial stages. With the further development of 
LOCs, the first category of LOC systems with conventional DSMs will gradually become 
disposable components employed on reusable laboratory instruments, except for POC 
devices. In fact, relevant companies in biomedical instruments have been moving in this 
direction. The second category of LOCs with unconventional DSMs is required in 
particular application scenarios, for example, in long-term biological experiments with 
complicated cell culturing. Traditional DSMs will be modified for specific contrived 
LOCs to realize a given purpose. The third category of LOCs is dependent on developing 
prognostic DSMs, which have not yet been established. Only the wide adoption of such 
prognostic LOCs will enable the establishment of relevant biomedical databases, which 
can then enable their diagnostic and prognostication functions. As the first category of 
LOCs is gradually commercialized, the second and third categories of LOCs will become 
mainstream in LOC research field. 
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